Clinical Pharmacology — MCQs

Q: Which antibiotic is MOST frequently implicated as a cause of drug-induced liver injury (DILI)?

Amoxicillin-clavulanic acid. **Amoxicillin-clavulanic acid (Co-amoxiclav)** is the most common cause of drug-induced liver injury (DILI) worldwide. The injury is typically **idiosyncratic** and characterized by a **cholestatic** pattern (elevated alkaline phosphatase and bilirubin), though mixed patterns can occur [1]. Interestingly, the injury is specifically attributed to the **clavulanic acid** component rather than the amoxicillin itself. It usually manifests within 1–3 weeks after starting the drug, but can occur even after the course is completed. **Analysis of Incorrect Options:** * **Oxacillin:** While anti-staphylococcal penicillins (like Oxacillin and Nafcillin) can cause transient elevations in transaminases or hepatitis, they are statistically less frequent causes of DILI compared to Co-amoxiclav [2]. * **Erythromycin:** Classically associated with **cholestatic hepatitis** (especially the estolate formulation), it was historically a major cause of DILI. However, its usage has declined in favor of newer macrolides, and it remains less frequent than Co-amoxiclav in modern epidemiological studies. * **Doxycycline:** Tetracyclines are generally associated with microvesicular steatosis (fatty liver), particularly with high-dose IV administration in pregnant women. Doxycycline is rarely implicated in severe DILI. **High-Yield Clinical Pearls for NEET-PG:** * **Most common drug class for DILI:** Antibiotics (overall). * **Most common single agent for DILI:** Amoxicillin-clavulanic acid. * **Pattern of Injury:** Co-amoxiclav typically causes a **cholestatic** pattern (Pruritus + Jaundice) [1]. * **Risk Factors:** Older age and male sex increase the risk for Co-amoxiclav-induced DILI. * **Other common culprits:** Isoniazid (Hepatocellular/Necrotic pattern), Valproate (Microvesicular steatosis), and Nitrofurantoin (Autoimmune-like hepatitis).

Q: Among the drugs used for Hepatitis B antiviral therapy, which of the following has the highest tendency for peripheral neuropathy?

Stavudine. **Explanation:** The correct answer is **Stavudine (d4T)**. **1. Why Stavudine is correct:** Stavudine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI). Its primary mechanism of toxicity involves the inhibition of **Mitochondrial DNA polymerase-gamma**. This leads to mitochondrial dysfunction, which clinically manifests as **distal symmetrical peripheral neuropathy** and lactic acidosis. Among the NRTIs, the "d-drugs" (Stavudine, Didanosine, and Zalcitabine) have the highest affinity for polymerase-gamma, making them the most notorious for causing nerve damage. **2. Analysis of Incorrect Options:** * **Lamivudine (3TC):** While also an NRTI used in both HIV and Hepatitis B, it is one of the least toxic drugs in its class. It has a very low affinity for mitochondrial DNA polymerase and rarely causes neuropathy. * **Zidovudine (AZT):** The hallmark side effect of Zidovudine is **bone marrow suppression** (anemia and neutropenia) and myopathy, rather than peripheral neuropathy. * **Nevirapine:** This is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Its most significant adverse effects are **hepatotoxicity** and severe skin rashes (including Stevens-Johnson Syndrome), not neuropathy. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Neuropathy:** Remember the **"3 Ds"** for peripheral neuropathy: **D**idanosine, **D**eoxycytidine (Zalcitabine), and **D**4T (Stavudine). * **Stavudine** is also strongly associated with **Lipoatrophy** (loss of subcutaneous fat from the face and limbs). * For Chronic Hepatitis B, **Tenofovir** and **Entecavir** are currently the preferred first-line agents due to high potency and a high genetic barrier to resistance.

Q: Which of the following drugs should not be given in renal failure?

Methicillin. **Explanation:** The correct answer is **Methicillin**. The primary reason Methicillin is contraindicated in renal failure is its significant association with **Acute Interstitial Nephritis (AIN)** [1]. Methicillin is a potent nephrotoxin that can cause hypersensitivity-mediated renal damage, potentially worsening pre-existing renal impairment or causing acute kidney injury [3]. Due to this high risk of nephrotoxicity, Methicillin has largely been replaced in clinical practice by safer alternatives like Cloxacillin or Nafcillin. **Analysis of Options:** * **Methicillin (Correct):** It is primarily excreted by the kidneys and is the classic prototype drug for drug-induced AIN [1]. Its use is avoided in patients with renal compromise to prevent further parenchymal damage [3]. * **Clindamycin:** This drug is primarily metabolized by the **liver** and excreted in the bile. Therefore, it does not require dose adjustment in renal failure and is considered safe. * **Amoxicillin:** While Amoxicillin is renally excreted, it is not inherently nephrotoxic. In cases of renal failure, the **dose is adjusted** (decreased frequency), but the drug is not strictly contraindicated. * **Rifampicin:** This is primarily metabolized by the **liver** and eliminated via the fecal/biliary route. It is safe to use in renal failure without significant dose modification. **NEET-PG High-Yield Pearls:** 1. **Safe in Renal Failure (No dose adjustment):** Clindamycin, Erythromycin, Rifampicin, Doxycycline, and Ceftriaxone. 2. **Drugs causing AIN:** Penicillins (Methicillin), NSAIDs, Sulphonamides, and Diuretics [1]. 3. **Doxycycline** is the tetracycline of choice in renal failure because it is excreted via the gut (biliary). 4. **Aminoglycosides and Amphotericin B** are the most common causes of Acute Tubular Necrosis (ATN) in clinical settings [2].

Q: A 60-year-old male presents with muscle pain, fatigue, and dark urine. His past medical history is significant for stable angina, and his current medications include atenolol, atorvastatin, and aspirin. His urine dipstick test is positive for blood, but urine microscopy did not reveal RBCs. Serum creatinine kinase was significantly elevated. Which of the following medications, if added to his regimen, is most likely to have precipitated this patient's condition?

Erythromycin. **Explanation:** The patient is presenting with **Statin-induced Rhabdomyolysis**, characterized by the triad of muscle pain, fatigue, and dark urine (myoglobinuria). The positive dipstick for blood without RBCs on microscopy is a classic indicator of **myoglobinuria** [1]. **Why Erythromycin is correct:** Atorvastatin is metabolized by the hepatic enzyme **CYP3A4**. **Erythromycin** is a potent **CYP3A4 inhibitor**. When added to a statin regimen, it inhibits the metabolism of the statin, leading to increased plasma concentrations and an elevated risk of skeletal muscle toxicity (myopathy/rhabdomyolysis) [2]. **Analysis of Incorrect Options:** * **B. Rifampin:** This is a potent **CYP450 inducer**. It would decrease the plasma levels of atorvastatin, potentially reducing its efficacy but not causing toxicity. * **C. Griseofulvin:** This is also a **CYP450 inducer** (primarily affecting CYP1A2 and 2C9) and is not associated with precipitating statin toxicity. * **D. Azithromycin:** Unlike Erythromycin and Clarithromycin, Azithromycin is a macrolide that **does not inhibit CYP3A4**. It is generally considered safe to use with statins. **High-Yield Clinical Pearls for NEET-PG:** * **Statins to remember:** Simvastatin, Lovastatin, and Atorvastatin are CYP3A4 substrates [2]. Pravastatin and Rosuvastatin are not significantly metabolized by CYP3A4 and have a lower risk of such interactions. * **Common CYP3A4 Inhibitors (The "SICKFACES.COM" mnemonic):** **S**odium valproate, **I**soniazid, **C**imetidine, **K**etoconazole, **F**luconazole, **A**lcohol (acute), **C**hloramphenicol, **E**rythromycin/Clarithromycin, **S**ulfonamides, **C**iprofloxacin, **O**meprazole, **M**etronidazole, and **Grapefruit juice**. * **Diagnostic Clue:** Myoglobinuria (Dipstick +ve for blood, Microscopy -ve for RBCs) + Elevated Creatine Kinase (CK) = Rhabdomyolysis [2].

Q: Which metabolic abnormality is caused by cyclosporine?

Hyperkalemia. **Explanation:** Cyclosporine is a Calcineurin Inhibitor (CNI) widely used as an immunosuppressant in organ transplantation and autoimmune disorders. **Why Hyperkalemia is correct:** Cyclosporine causes **Hyperkalemia** primarily through two mechanisms: 1. **Renal Vasoconstriction:** It induces potent vasoconstriction of the afferent arterioles, reducing renal blood flow and the Glomerular Filtration Rate (GFR). 2. **Hyporeninemic Hypoaldosteronism:** It suppresses the production of renin and aldosterone. Reduced aldosterone levels lead to decreased potassium excretion in the distal nephron [1]. Additionally, it inhibits the mineralocorticoid receptor-mediated sodium-potassium exchange, further elevating serum potassium levels. **Why other options are incorrect:** * **Hypokalemia:** This is incorrect because cyclosporine consistently impairs potassium excretion rather than promoting it. * **Hypercalcemia/Hypocalcemia:** Cyclosporine does not significantly impact calcium homeostasis directly. However, it is more commonly associated with **Hypomagnesemia** due to renal magnesium wasting. **High-Yield Clinical Pearls for NEET-PG:** * **The "Hyper" Mnemonic for Cyclosporine side effects:** **Hyper**kalemia, **Hyper**tension, **Hyper**lipidemia, **Hyper**glycemia, and **Hyper**trichosis (Hirsutism). * **Gingival Hyperplasia:** A classic physical finding associated with cyclosporine (also seen with Phenytoin and Nifedipine). * **Nephrotoxicity:** This is the most common dose-limiting side effect. * **Comparison:** Unlike Cyclosporine, **Tacrolimus** (another CNI) does not cause hirsutism or gingival hyperplasia but is more likely to cause post-transplant diabetes mellitus.

Q: Which of the following drugs is most commonly associated with noninfectious chronic meningitis due to drug hypersensitivity?

Ibuprofen. The clinical entity described is **Drug-Induced Aseptic Meningitis (DIAM)**. This is a rare but important hypersensitivity reaction (Type III or IV) characterized by meningeal inflammation [1] in the absence of an infectious pathogen. **Why Ibuprofen is Correct:** **NSAIDs**, particularly **Ibuprofen**, are the most frequently implicated class of drugs causing DIAM. It typically presents with classic meningeal signs (fever, headache, neck stiffness) within hours of ingestion [1],[2]. A key diagnostic feature is that the symptoms resolve rapidly upon drug discontinuation but recur promptly upon re-exposure. It is most commonly seen in patients with underlying autoimmune conditions, especially **Systemic Lupus Erythematosus (SLE)**. **Analysis of Incorrect Options:** * **Acetaminophen:** While a common analgesic, it is not associated with aseptic meningitis. Its primary toxicity is dose-dependent hepatotoxicity. * **Acyclovir:** Acyclovir is more commonly associated with **obstructive uropathy** (due to crystal formation in renal tubules) or **neurotoxicity** (confusion, tremors), but not typically hypersensitivity-mediated meningitis. * **Beta-lactams:** While antibiotics like Penicillins and Cephalosporins [2] can cause DIAM, they are less frequently the culprit compared to Ibuprofen in clinical practice and board examinations. **High-Yield Pearls for NEET-PG:** * **CSF Findings in DIAM:** Neutrophilic pleocytosis (mimicking bacterial meningitis), elevated protein, and normal glucose levels. * **Common Culprits (Mnemonic: "N-A-I-L"):** **N**SAIDs (Ibuprofen), **A**ntibiotics (TMP-SMX), **I**VIG, **L**amotrigine. * **Risk Factor:** Patients with **SLE** or Mixed Connective Tissue Disease (MCTD) are at a significantly higher risk for Ibuprofen-induced DIAM.

Q: Which of the following antitubercular drug combinations is preferred in patients with severe liver disease?

Streptomycin + Ethambutol. **Explanation:** The management of tuberculosis in patients with severe liver disease (such as cirrhosis or acute hepatitis) requires a shift from the standard hepatotoxic regimen to one containing **non-hepatotoxic drugs** [1]. **1. Why Streptomycin + Ethambutol is correct:** Most first-line antitubercular drugs (HRZ) are metabolized by the liver and carry a risk of drug-induced liver injury (DILI). **Ethambutol** and **Streptomycin** are the only two primary drugs that are primarily excreted by the kidneys and are **not hepatotoxic** [1]. Therefore, in patients with unstable or severe liver disease, a combination of these two drugs (often supplemented by a fluoroquinolone like Levofloxacin) is the safest choice to avoid further hepatic decompensation. **2. Why the other options are incorrect:** * **Isoniazid (H), Rifampicin (R), and Pyrazinamide (Z)** are all hepatotoxic. * **Pyrazinamide** is the most hepatotoxic, followed by **Isoniazid**, and then **Rifampicin**. * **Options A, C, and D** all contain at least one of these hepatotoxic agents (Isoniazid or Rifampicin), making them unsuitable for patients with severe, unstable liver dysfunction. **Clinical Pearls for NEET-PG:** * **Hepatotoxicity Order:** Pyrazinamide > Isoniazid > Rifampicin. * **WHO Guidelines for Liver Disease [1]:** * *Stable/Mild disease:* 2HRE + 7HR. * *Severe/Unstable disease:* 18–24 months of Streptomycin + Ethambutol + Fluoroquinolone. * **Monitoring:** In standard therapy, if AST/ALT levels rise >3 times the upper limit of normal (ULN) with symptoms, or >5 times ULN without symptoms, all hepatotoxic drugs must be stopped immediately.

Q: All of the following cause hypertension except?

L-Dopa. **Explanation:** The correct answer is **L-Dopa**. While many drugs induce hypertension, L-Dopa is primarily associated with **orthostatic hypotension**. **1. Why L-Dopa is the correct answer:** L-Dopa (Levodopa) is a precursor to dopamine. In the peripheral circulation, dopamine acts on D1 receptors causing vasodilation and on $\beta_1$ receptors in the heart. However, its most significant clinical effect on blood pressure is **hypotension**, occurring in approximately 30% of patients. This is due to both peripheral vasodilation and the inhibition of central sympathetic outflow. **2. Why the other options are incorrect:** * **NSAIDs:** These inhibit cyclooxygenase (COX) enzymes, leading to decreased synthesis of vasodilatory prostaglandins ($PGE_2$ and $PGI_2$). This results in sodium and water retention and increased peripheral vascular resistance, elevating blood pressure. * **Cyclosporine:** This calcineurin inhibitor causes potent renal afferent arteriolar vasoconstriction and increases endothelin production, leading to significant systemic hypertension in up to 50% of transplant patients. * **Erythropoietin (EPO):** EPO-induced hypertension is a well-known side effect in patients with chronic kidney disease. It occurs due to an increase in whole-blood viscosity and direct vasoconstrictive effects on vascular smooth muscle. **Clinical Pearls for NEET-PG:** * **Drug-Induced Hypertension "Hot List":** OCPs (most common cause in young women), Steroids, Licorice, SNRIs (Venlafaxine), and VEGF inhibitors. * **L-Dopa Side Effects:** Remember the "On-Off" phenomenon, dyskinesias, and psychosis. To minimize peripheral side effects like hypotension and vomiting, L-Dopa is always co-administered with a peripheral decarboxylase inhibitor (Carbidopa).

A 60-year-old male presents with muscle pain, fatigue, and dark urine. His past medical history is significant for stable angina, and his current medications include atenolol, atorvastatin, and aspirin. His urine dipstick test is positive for blood, but urine microscopy did not reveal RBCs. Serum creatinine kinase was significantly elevated. Which of the following medications, if added to his regimen, is most likely to have precipitated this patient's condition?

Q6Easy

Which metabolic abnormality is caused by cyclosporine?

Q7Medium

A 40-year-old lady presents to casualty with abdominal pain and vomiting. She also reports hearing people conspiring to harm her, and visual hallucinations. These symptoms started along with the abdominal pain following the use of barbiturates. What is the most likely diagnosis?

Q8Medium

Which of the following drugs is most commonly associated with noninfectious chronic meningitis due to drug hypersensitivity?

Q9Medium

Which of the following antitubercular drug combinations is preferred in patients with severe liver disease?

Q10Easy

All of the following cause hypertension except?

Clinical Pharmacology Indian Medical PG Practice Questions and MCQs

Question 1: A diabetic female on Isoniazid (INH) and Rifampicin for tuberculosis developed Deep Vein Thrombosis (DVT). She was started on Warfarin, but her Prothrombin Time (PT) is not elevated. What is the next appropriate step in management?

A. Increase the dose of Warfarin
B. Replace Warfarin with Acenocoumarol
C. Switch Ethambutol for Rifampicin
D. Use Low Molecular Weight Heparin (LMWH) (Correct Answer)

Explanation: ### Explanation **1. Why LMWH is the Correct Choice:** The patient is taking **Rifampicin**, a potent **cytochrome P450 (CYP3A4 and CYP2C9) enzyme inducer**. Warfarin is metabolized by these enzymes; therefore, Rifampicin significantly increases Warfarin metabolism, leading to subtherapeutic levels and a failure to elevate the Prothrombin Time (PT/INR). In the acute management of DVT, achieving rapid and reliable anticoagulation is critical [1]. Since the drug interaction makes Warfarin unpredictable and difficult to titrate, switching to **Low Molecular Weight Heparin (LMWH)** is the most appropriate step. LMWH does not rely on the CYP450 system and provides immediate, predictable anticoagulation [2]. **2. Analysis of Incorrect Options:** * **Option A (Increase Warfarin dose):** While theoretically possible, the induction effect of Rifampicin is so profound that extremely high doses of Warfarin would be required, making the INR highly unstable and increasing the risk of toxicity if Rifampicin is later discontinued. * **Option B (Replace with Acenocoumarol):** Acenocoumarol is also a Vitamin K antagonist metabolized by the liver; it shares the same metabolic pathways and drug interactions as Warfarin [1]. * **Option C (Switch Ethambutol for Rifampicin):** Rifampicin is a cornerstone of Short Course Chemotherapy (SCC) for TB. It should not be discontinued or replaced with a less potent drug like Ethambutol solely to accommodate Warfarin, as this risks treatment failure or MDR-TB. **3. NEET-PG High-Yield Pearls:** * **Rifampicin:** The "Great Inducer." It reduces the efficacy of Warfarin, Oral Contraceptive Pills (OCPs), Sulfonylureas, and Digoxin. * **Isoniazid (INH):** Conversely, INH is a CYP enzyme **inhibitor**, but in this clinical scenario, the inducing effect of Rifampicin dominates. * **Management Rule:** When a patient on Rifampicin requires anticoagulation, LMWH or Fondaparinux are preferred over Vitamin K antagonists due to predictable pharmacokinetics [2].

Question 2: Which antibiotic is MOST frequently implicated as a cause of drug-induced liver injury (DILI)?

A. Amoxicillin-clavulanic acid (Correct Answer)
B. Oxacillin
C. Erythromycin
D. Doxycycline

Explanation: **Amoxicillin-clavulanic acid (Co-amoxiclav)** is the most common cause of drug-induced liver injury (DILI) worldwide. The injury is typically **idiosyncratic** and characterized by a **cholestatic** pattern (elevated alkaline phosphatase and bilirubin), though mixed patterns can occur [1]. Interestingly, the injury is specifically attributed to the **clavulanic acid** component rather than the amoxicillin itself. It usually manifests within 1–3 weeks after starting the drug, but can occur even after the course is completed. **Analysis of Incorrect Options:** * **Oxacillin:** While anti-staphylococcal penicillins (like Oxacillin and Nafcillin) can cause transient elevations in transaminases or hepatitis, they are statistically less frequent causes of DILI compared to Co-amoxiclav [2]. * **Erythromycin:** Classically associated with **cholestatic hepatitis** (especially the estolate formulation), it was historically a major cause of DILI. However, its usage has declined in favor of newer macrolides, and it remains less frequent than Co-amoxiclav in modern epidemiological studies. * **Doxycycline:** Tetracyclines are generally associated with microvesicular steatosis (fatty liver), particularly with high-dose IV administration in pregnant women. Doxycycline is rarely implicated in severe DILI. **High-Yield Clinical Pearls for NEET-PG:** * **Most common drug class for DILI:** Antibiotics (overall). * **Most common single agent for DILI:** Amoxicillin-clavulanic acid. * **Pattern of Injury:** Co-amoxiclav typically causes a **cholestatic** pattern (Pruritus + Jaundice) [1]. * **Risk Factors:** Older age and male sex increase the risk for Co-amoxiclav-induced DILI. * **Other common culprits:** Isoniazid (Hepatocellular/Necrotic pattern), Valproate (Microvesicular steatosis), and Nitrofurantoin (Autoimmune-like hepatitis).

Question 3: Among the drugs used for Hepatitis B antiviral therapy, which of the following has the highest tendency for peripheral neuropathy?

A. Lamivudine
B. Zidovudine
C. Stavudine (Correct Answer)
D. Nevirapine

Explanation: **Explanation:** The correct answer is **Stavudine (d4T)**. **1. Why Stavudine is correct:** Stavudine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI). Its primary mechanism of toxicity involves the inhibition of **Mitochondrial DNA polymerase-gamma**. This leads to mitochondrial dysfunction, which clinically manifests as **distal symmetrical peripheral neuropathy** and lactic acidosis. Among the NRTIs, the "d-drugs" (Stavudine, Didanosine, and Zalcitabine) have the highest affinity for polymerase-gamma, making them the most notorious for causing nerve damage. **2. Analysis of Incorrect Options:** * **Lamivudine (3TC):** While also an NRTI used in both HIV and Hepatitis B, it is one of the least toxic drugs in its class. It has a very low affinity for mitochondrial DNA polymerase and rarely causes neuropathy. * **Zidovudine (AZT):** The hallmark side effect of Zidovudine is **bone marrow suppression** (anemia and neutropenia) and myopathy, rather than peripheral neuropathy. * **Nevirapine:** This is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Its most significant adverse effects are **hepatotoxicity** and severe skin rashes (including Stevens-Johnson Syndrome), not neuropathy. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Neuropathy:** Remember the **"3 Ds"** for peripheral neuropathy: **D**idanosine, **D**eoxycytidine (Zalcitabine), and **D**4T (Stavudine). * **Stavudine** is also strongly associated with **Lipoatrophy** (loss of subcutaneous fat from the face and limbs). * For Chronic Hepatitis B, **Tenofovir** and **Entecavir** are currently the preferred first-line agents due to high potency and a high genetic barrier to resistance.

Question 4: Which of the following drugs should not be given in renal failure?

A. Clindamycin
B. Methicillin (Correct Answer)
C. Amoxicillin
D. Rifampicin

Explanation: **Explanation:** The correct answer is **Methicillin**. The primary reason Methicillin is contraindicated in renal failure is its significant association with **Acute Interstitial Nephritis (AIN)** [1]. Methicillin is a potent nephrotoxin that can cause hypersensitivity-mediated renal damage, potentially worsening pre-existing renal impairment or causing acute kidney injury [3]. Due to this high risk of nephrotoxicity, Methicillin has largely been replaced in clinical practice by safer alternatives like Cloxacillin or Nafcillin. **Analysis of Options:** * **Methicillin (Correct):** It is primarily excreted by the kidneys and is the classic prototype drug for drug-induced AIN [1]. Its use is avoided in patients with renal compromise to prevent further parenchymal damage [3]. * **Clindamycin:** This drug is primarily metabolized by the **liver** and excreted in the bile. Therefore, it does not require dose adjustment in renal failure and is considered safe. * **Amoxicillin:** While Amoxicillin is renally excreted, it is not inherently nephrotoxic. In cases of renal failure, the **dose is adjusted** (decreased frequency), but the drug is not strictly contraindicated. * **Rifampicin:** This is primarily metabolized by the **liver** and eliminated via the fecal/biliary route. It is safe to use in renal failure without significant dose modification. **NEET-PG High-Yield Pearls:** 1. **Safe in Renal Failure (No dose adjustment):** Clindamycin, Erythromycin, Rifampicin, Doxycycline, and Ceftriaxone. 2. **Drugs causing AIN:** Penicillins (Methicillin), NSAIDs, Sulphonamides, and Diuretics [1]. 3. **Doxycycline** is the tetracycline of choice in renal failure because it is excreted via the gut (biliary). 4. **Aminoglycosides and Amphotericin B** are the most common causes of Acute Tubular Necrosis (ATN) in clinical settings [2].

Question 5: A 60-year-old male presents with muscle pain, fatigue, and dark urine. His past medical history is significant for stable angina, and his current medications include atenolol, atorvastatin, and aspirin. His urine dipstick test is positive for blood, but urine microscopy did not reveal RBCs. Serum creatinine kinase was significantly elevated. Which of the following medications, if added to his regimen, is most likely to have precipitated this patient's condition?

A. Erythromycin (Correct Answer)
B. Rifampin
C. Griseofulvin
D. Azithromycin

Explanation: **Explanation:** The patient is presenting with **Statin-induced Rhabdomyolysis**, characterized by the triad of muscle pain, fatigue, and dark urine (myoglobinuria). The positive dipstick for blood without RBCs on microscopy is a classic indicator of **myoglobinuria** [1]. **Why Erythromycin is correct:** Atorvastatin is metabolized by the hepatic enzyme **CYP3A4**. **Erythromycin** is a potent **CYP3A4 inhibitor**. When added to a statin regimen, it inhibits the metabolism of the statin, leading to increased plasma concentrations and an elevated risk of skeletal muscle toxicity (myopathy/rhabdomyolysis) [2]. **Analysis of Incorrect Options:** * **B. Rifampin:** This is a potent **CYP450 inducer**. It would decrease the plasma levels of atorvastatin, potentially reducing its efficacy but not causing toxicity. * **C. Griseofulvin:** This is also a **CYP450 inducer** (primarily affecting CYP1A2 and 2C9) and is not associated with precipitating statin toxicity. * **D. Azithromycin:** Unlike Erythromycin and Clarithromycin, Azithromycin is a macrolide that **does not inhibit CYP3A4**. It is generally considered safe to use with statins. **High-Yield Clinical Pearls for NEET-PG:** * **Statins to remember:** Simvastatin, Lovastatin, and Atorvastatin are CYP3A4 substrates [2]. Pravastatin and Rosuvastatin are not significantly metabolized by CYP3A4 and have a lower risk of such interactions. * **Common CYP3A4 Inhibitors (The "SICKFACES.COM" mnemonic):** **S**odium valproate, **I**soniazid, **C**imetidine, **K**etoconazole, **F**luconazole, **A**lcohol (acute), **C**hloramphenicol, **E**rythromycin/Clarithromycin, **S**ulfonamides, **C**iprofloxacin, **O**meprazole, **M**etronidazole, and **Grapefruit juice**. * **Diagnostic Clue:** Myoglobinuria (Dipstick +ve for blood, Microscopy -ve for RBCs) + Elevated Creatine Kinase (CK) = Rhabdomyolysis [2].

Question 6: Which metabolic abnormality is caused by cyclosporine?

A. Hyperkalemia (Correct Answer)
B. Hypokalemia
C. Hypercalcemia
D. Hypocalcemia

Explanation: **Explanation:** Cyclosporine is a Calcineurin Inhibitor (CNI) widely used as an immunosuppressant in organ transplantation and autoimmune disorders. **Why Hyperkalemia is correct:** Cyclosporine causes **Hyperkalemia** primarily through two mechanisms: 1. **Renal Vasoconstriction:** It induces potent vasoconstriction of the afferent arterioles, reducing renal blood flow and the Glomerular Filtration Rate (GFR). 2. **Hyporeninemic Hypoaldosteronism:** It suppresses the production of renin and aldosterone. Reduced aldosterone levels lead to decreased potassium excretion in the distal nephron [1]. Additionally, it inhibits the mineralocorticoid receptor-mediated sodium-potassium exchange, further elevating serum potassium levels. **Why other options are incorrect:** * **Hypokalemia:** This is incorrect because cyclosporine consistently impairs potassium excretion rather than promoting it. * **Hypercalcemia/Hypocalcemia:** Cyclosporine does not significantly impact calcium homeostasis directly. However, it is more commonly associated with **Hypomagnesemia** due to renal magnesium wasting. **High-Yield Clinical Pearls for NEET-PG:** * **The "Hyper" Mnemonic for Cyclosporine side effects:** **Hyper**kalemia, **Hyper**tension, **Hyper**lipidemia, **Hyper**glycemia, and **Hyper**trichosis (Hirsutism). * **Gingival Hyperplasia:** A classic physical finding associated with cyclosporine (also seen with Phenytoin and Nifedipine). * **Nephrotoxicity:** This is the most common dose-limiting side effect. * **Comparison:** Unlike Cyclosporine, **Tacrolimus** (another CNI) does not cause hirsutism or gingival hyperplasia but is more likely to cause post-transplant diabetes mellitus.

Question 7: A 40-year-old lady presents to casualty with abdominal pain and vomiting. She also reports hearing people conspiring to harm her, and visual hallucinations. These symptoms started along with the abdominal pain following the use of barbiturates. What is the most likely diagnosis?

A. Acute Intermittent Porphyria (Correct Answer)
B. Ketoacidosis
C. Hyperthyroidism
D. Conversion Disorder

Explanation: ### Explanation **Correct Answer: A. Acute Intermittent Porphyria (AIP)** The clinical triad of **abdominal pain, neuropsychiatric symptoms (hallucinations/paranoia), and a history of drug triggers** is classic for Acute Intermittent Porphyria [1]. * **Pathophysiology:** AIP is an autosomal dominant disorder caused by a deficiency of **Porphobilinogen (PBG) deaminase**. This leads to the accumulation of toxic heme precursors, ALA and PBG [1]. * **The Trigger:** Barbiturates are potent inducers of the **Cytochrome P450** system. This increases the demand for heme, stimulating the enzyme **ALA synthase**, which results in a massive surge of toxic precursors, precipitating an acute attack. Specific triggers identified include drugs such as anticonvulsants (barbiturates), sulphonamides, and oestrogens [1]. * **Clinical Presentation:** Often described as the "Little Imitator," it presents with severe "painful abdomen" (but no signs of peritonitis), peripheral neuropathy, and psychiatric disturbances (psychosis, anxiety) [1]. **Why Incorrect Options are Wrong:** * **B. Ketoacidosis:** While it causes abdominal pain and vomiting, it typically presents with Kussmaul breathing, dehydration, and altered sensorium, rather than complex auditory/visual hallucinations triggered by barbiturates. * **C. Hyperthyroidism:** Can cause anxiety and palpitations (Thyroid Storm), but the specific association with barbiturate-induced abdominal pain and psychosis is not characteristic. * **D. Conversion Disorder:** This is a diagnosis of exclusion. The presence of a specific pharmacological trigger (barbiturates) and severe systemic symptoms points toward an organic metabolic cause. **High-Yield NEET-PG Pearls:** * **The 5 P's of AIP:** **P**ainful abdomen, **P**olyneuropathy, **P**sychological disturbances, **P**ink urine (on standing/exposure to light), and **P**recipitated by drugs [1]. * **Diagnosis:** Elevated urinary **PBG** levels during an attack (Hoesch test or Watson-Schwartz test). * **Management:** Avoid triggers, administer **Intravenous Hemin** (inhibits ALA synthase), and give **High-dose Glucose** (suppresses ALA synthase). * **Safe Drugs:** Morphine, Aspirin, Penicillin. * **Unsafe Drugs:** Barbiturates, Sulfonamides, Oral Contraceptive Pills [1].

Question 8: Which of the following drugs is most commonly associated with noninfectious chronic meningitis due to drug hypersensitivity?

A. Acetaminophen
B. Ibuprofen (Correct Answer)
C. Acyclovir
D. Beta-lactams

Explanation: The clinical entity described is **Drug-Induced Aseptic Meningitis (DIAM)**. This is a rare but important hypersensitivity reaction (Type III or IV) characterized by meningeal inflammation [1] in the absence of an infectious pathogen. **Why Ibuprofen is Correct:** **NSAIDs**, particularly **Ibuprofen**, are the most frequently implicated class of drugs causing DIAM. It typically presents with classic meningeal signs (fever, headache, neck stiffness) within hours of ingestion [1],[2]. A key diagnostic feature is that the symptoms resolve rapidly upon drug discontinuation but recur promptly upon re-exposure. It is most commonly seen in patients with underlying autoimmune conditions, especially **Systemic Lupus Erythematosus (SLE)**. **Analysis of Incorrect Options:** * **Acetaminophen:** While a common analgesic, it is not associated with aseptic meningitis. Its primary toxicity is dose-dependent hepatotoxicity. * **Acyclovir:** Acyclovir is more commonly associated with **obstructive uropathy** (due to crystal formation in renal tubules) or **neurotoxicity** (confusion, tremors), but not typically hypersensitivity-mediated meningitis. * **Beta-lactams:** While antibiotics like Penicillins and Cephalosporins [2] can cause DIAM, they are less frequently the culprit compared to Ibuprofen in clinical practice and board examinations. **High-Yield Pearls for NEET-PG:** * **CSF Findings in DIAM:** Neutrophilic pleocytosis (mimicking bacterial meningitis), elevated protein, and normal glucose levels. * **Common Culprits (Mnemonic: "N-A-I-L"):** **N**SAIDs (Ibuprofen), **A**ntibiotics (TMP-SMX), **I**VIG, **L**amotrigine. * **Risk Factor:** Patients with **SLE** or Mixed Connective Tissue Disease (MCTD) are at a significantly higher risk for Ibuprofen-induced DIAM.

Question 9: Which of the following antitubercular drug combinations is preferred in patients with severe liver disease?

A. Streptomycin + Isoniazid
B. Streptomycin + Ethambutol (Correct Answer)
C. Isoniazid + Rifampicin
D. Rifampicin + Ethambutol

Explanation: **Explanation:** The management of tuberculosis in patients with severe liver disease (such as cirrhosis or acute hepatitis) requires a shift from the standard hepatotoxic regimen to one containing **non-hepatotoxic drugs** [1]. **1. Why Streptomycin + Ethambutol is correct:** Most first-line antitubercular drugs (HRZ) are metabolized by the liver and carry a risk of drug-induced liver injury (DILI). **Ethambutol** and **Streptomycin** are the only two primary drugs that are primarily excreted by the kidneys and are **not hepatotoxic** [1]. Therefore, in patients with unstable or severe liver disease, a combination of these two drugs (often supplemented by a fluoroquinolone like Levofloxacin) is the safest choice to avoid further hepatic decompensation. **2. Why the other options are incorrect:** * **Isoniazid (H), Rifampicin (R), and Pyrazinamide (Z)** are all hepatotoxic. * **Pyrazinamide** is the most hepatotoxic, followed by **Isoniazid**, and then **Rifampicin**. * **Options A, C, and D** all contain at least one of these hepatotoxic agents (Isoniazid or Rifampicin), making them unsuitable for patients with severe, unstable liver dysfunction. **Clinical Pearls for NEET-PG:** * **Hepatotoxicity Order:** Pyrazinamide > Isoniazid > Rifampicin. * **WHO Guidelines for Liver Disease [1]:** * *Stable/Mild disease:* 2HRE + 7HR. * *Severe/Unstable disease:* 18–24 months of Streptomycin + Ethambutol + Fluoroquinolone. * **Monitoring:** In standard therapy, if AST/ALT levels rise >3 times the upper limit of normal (ULN) with symptoms, or >5 times ULN without symptoms, all hepatotoxic drugs must be stopped immediately.

Question 10: All of the following cause hypertension except?

A. NSAID
B. L-Dopa (Correct Answer)
C. Cyclosporine
D. Erythropoietin

Explanation: **Explanation:** The correct answer is **L-Dopa**. While many drugs induce hypertension, L-Dopa is primarily associated with **orthostatic hypotension**. **1. Why L-Dopa is the correct answer:** L-Dopa (Levodopa) is a precursor to dopamine. In the peripheral circulation, dopamine acts on D1 receptors causing vasodilation and on $\beta_1$ receptors in the heart. However, its most significant clinical effect on blood pressure is **hypotension**, occurring in approximately 30% of patients. This is due to both peripheral vasodilation and the inhibition of central sympathetic outflow. **2. Why the other options are incorrect:** * **NSAIDs:** These inhibit cyclooxygenase (COX) enzymes, leading to decreased synthesis of vasodilatory prostaglandins ($PGE_2$ and $PGI_2$). This results in sodium and water retention and increased peripheral vascular resistance, elevating blood pressure. * **Cyclosporine:** This calcineurin inhibitor causes potent renal afferent arteriolar vasoconstriction and increases endothelin production, leading to significant systemic hypertension in up to 50% of transplant patients. * **Erythropoietin (EPO):** EPO-induced hypertension is a well-known side effect in patients with chronic kidney disease. It occurs due to an increase in whole-blood viscosity and direct vasoconstrictive effects on vascular smooth muscle. **Clinical Pearls for NEET-PG:** * **Drug-Induced Hypertension "Hot List":** OCPs (most common cause in young women), Steroids, Licorice, SNRIs (Venlafaxine), and VEGF inhibitors. * **L-Dopa Side Effects:** Remember the "On-Off" phenomenon, dyskinesias, and psychosis. To minimize peripheral side effects like hypotension and vomiting, L-Dopa is always co-administered with a peripheral decarboxylase inhibitor (Carbidopa).

Question 11: A 50-year-old female with rheumatoid arthritis is being considered for infliximab therapy. Which of the following tests should be performed before beginning treatment?

A. Liver function tests
B. PPD skin test (Correct Answer)
C. Pulmonary function tests
D. Visual examination

Explanation: **Explanation:** **Infliximab** is a chimeric monoclonal antibody that inhibits **Tumor Necrosis Factor-alpha (TNF-α)**. TNF-α plays a critical role in the immune system's ability to form and maintain **granulomas**, which sequester *Mycobacterium tuberculosis*. 1. **Why the PPD skin test is correct:** By inhibiting TNF-α, infliximab can cause the breakdown of existing granulomas [1], leading to the **reactivation of Latent Tuberculosis Infection (LTBI)**. This can result in severe, disseminated, or miliary tuberculosis. Therefore, all patients must be screened for TB using a PPD (Tuberculin) skin test or an Interferon-Gamma Release Assay (IGRA) [2] and a chest X-ray before initiating therapy. If LTBI is detected, prophylactic treatment (e.g., Isoniazid) must be started before the biologic. 2. **Why other options are incorrect:** * **Liver Function Tests (A):** While some biologics can cause hepatotoxicity, they are not the primary mandatory screening requirement compared to TB screening. * **Pulmonary Function Tests (C):** These are typically required for drugs causing interstitial lung disease, such as **Methotrexate** [1] or **Amiodarone**, but not routinely for Infliximab. * **Visual Examination (D):** This is mandatory for patients starting **Hydroxychloroquine** (to monitor for bull’s eye maculopathy) or **Ethambutol**, but not for TNF inhibitors. **NEET-PG High-Yield Pearls:** * **TNF-α Inhibitors:** Include Infliximab, Adalimumab, and Etanercept [1]. * **Contraindications:** Avoid TNF inhibitors in patients with **NYHA Class III/IV Heart Failure** (can worsen outcomes) and active infections. * **Screening:** Always screen for **Hepatitis B** and **TB** before starting any biologic DMARD. * **Vaccination:** Live vaccines are contraindicated while on TNF-inhibitor therapy.

Question 12: A 14-year-old presented with recurrent epistaxis along with characteristic skin and mucous membrane lesions. The lesions were seen at the dorsum of the tongue, oral cavity, buccal mucosa, lips, palate, and nasal mucosa. Lab findings revealed a normal coagulation profile. Which of the following drugs has been recently approved for this condition?

A. Bevacizumab (Correct Answer)
B. Ranibizumab
C. Transtuzumab
D. Sorafenib

Explanation: ### Explanation **Diagnosis: Hereditary Hemorrhagic Telangiectasia (HHT) / Osler-Weber-Rendu Syndrome** The clinical presentation of recurrent epistaxis, characteristic telangiectasias on the tongue, lips, and oral mucosa, and a normal coagulation profile is diagnostic of **Hereditary Hemorrhagic Telangiectasia (HHT)** [1], [2]. HHT is an autosomal dominant disorder characterized by vascular malformations (AVMs) and angiodysplasia. **1. Why Bevacizumab is Correct:** The underlying pathophysiology of HHT involves the over-expression of **Vascular Endothelial Growth Factor (VEGF)**, which leads to fragile, disorganized vessel formation. **Bevacizumab** is a humanized monoclonal antibody that inhibits VEGF. Recent clinical trials and guidelines (including International HHT Guidelines) have approved its use (off-label but standard of care) for reducing the frequency and severity of epistaxis and managing high-output heart failure caused by hepatic AVMs in HHT patients. **2. Analysis of Incorrect Options:** * **Ranibizumab:** While also an anti-VEGF agent, it is a monoclonal antibody fragment primarily used via intravitreal injection for ophthalmological conditions like wet AMD and macular edema. It is not used systemically for HHT. * **Trastuzumab:** A monoclonal antibody targeting the **HER2/neu** receptor. It is used in HER2-positive breast and gastric cancers, having no role in vascular malformations. * **Sorafenib:** A multikinase inhibitor (targeting Raf, VEGF-R, and PDGF-R) used primarily for Hepatocellular Carcinoma (HCC) and Renal Cell Carcinoma (RCC). It is not the drug of choice for HHT. **3. Clinical Pearls for NEET-PG:** * **Inheritance:** Autosomal Dominant [1]. * **Triad:** Epistaxis, Telangiectasias, and Family History. * **Curacao Criteria:** Used for diagnosis (Epistaxis, Telangiectasia, Visceral lesions, First-degree relative). * **Complications:** Paradoxical embolism (due to pulmonary AVMs) leading to brain abscesses or stroke [1]. * **High-Yield Management:** Iron supplementation for anemia [1]; Bevacizumab for refractory bleeding.

Question 13: A diabetic patient with Enterococcus faecalis sepsis, on intravenous Linezolid, developed high anion gap metabolic acidosis with increased serum lactate and negative ketones. What is the most probable acid-base abnormality?

A. Type A lactic acidosis due to septic shock
B. Metabolic acidosis of uncertain etiology
C. Diabetic ketoacidosis
D. Type B lactic acidosis due to linezolid (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Type B lactic acidosis due to linezolid** Linezolid is an oxazolidinone antibiotic that inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit. However, it can also interfere with **mammalian mitochondrial protein synthesis** due to the structural similarity between bacterial ribosomes and mitochondrial ribosomes. This leads to mitochondrial dysfunction, impairing the aerobic respiratory chain and forcing cells into anaerobic metabolism. The resulting accumulation of lactate occurs **without evidence of tissue hypoxia or hypoperfusion**, which is the hallmark of **Type B Lactic Acidosis** [1]. **Why other options are incorrect:** * **Option A:** Type A lactic acidosis is caused by tissue hypoxia (e.g., septic shock, cardiogenic shock) [1]. While the patient has sepsis, the question does not mention hypotension or signs of poor perfusion; the specific association with Linezolid points toward a drug-induced (Type B) etiology. * **Option B:** The etiology is not "uncertain" because the temporal relationship between Linezolid use and the development of hyperlactatemia is a well-documented clinical phenomenon. * **Option C:** Diabetic ketoacidosis (DKA) is ruled out by the mention of **negative ketones** and the specific finding of increased serum lactate [2]. DKA typically presents with signs like dehydration, air hunger, and the smell of acetone [2]. **Clinical Pearls for NEET-PG:** * **Linezolid Side Effects:** 1. **Hematologic:** Thrombocytopenia (most common with >2 weeks of use). 2. **Neurologic:** Optic and peripheral neuropathy. 3. **Metabolic:** Type B Lactic Acidosis. 4. **Drug Interaction:** Serotonin Syndrome (when used with SSRIs/MAO inhibitors). * **Lactic Acidosis Classification:** * **Type A:** Hypoxic (Shock, severe anemia, CO poisoning) [1]. * **Type B:** Non-hypoxic (Drugs like Metformin, Linezolid, NRTIs; Malignancy; Liver failure) [1].

Question 14: Which of the following is NOT a cause of hyperkalemia?

A. Digoxin (Correct Answer)
B. Potassium-sparing diuretic
C. Renin-angiotensin system blockers
D. Cyclosporine

Explanation: **Explanation:** The question asks for the drug that is **NOT** a cause of hyperkalemia. However, there is a clinical nuance here: while **Digoxin toxicity** classically causes hyperkalemia, therapeutic doses do not typically result in significant elevation of serum potassium. In the context of standard NEET-PG pharmacology, the other three options are classic, potent causes of drug-induced hyperkalemia. **1. Why Digoxin is the Correct Answer (Contextual):** Digoxin inhibits the **Na+/K+-ATPase pump**. In cases of **acute toxicity**, this inhibition prevents potassium from entering the cells, leading to severe hyperkalemia. However, at therapeutic levels, this effect is minimal. In many MCQ formats, Digoxin is singled out because its relationship with potassium is bidirectional: **hypokalemia** actually predisposes a patient to Digoxin toxicity (by increasing digoxin binding to the ATPase pump). **2. Why the other options are wrong:** * **Potassium-sparing diuretics (e.g., Spironolactone, Amiloride):** These act on the distal nephron to inhibit sodium reabsorption and potassium secretion, directly increasing serum potassium. * **Renin-Angiotensin System (RAS) Blockers (ACE inhibitors/ARBs):** These drugs decrease Aldosterone levels [1]. Since aldosterone is responsible for potassium excretion in the collecting duct, its inhibition leads to potassium retention [1]. * **Cyclosporine:** This calcineurin inhibitor causes hyperkalemia by suppressing aldosterone synthesis and inducing tubular resistance to aldosterone. **High-Yield Clinical Pearls for NEET-PG:** * **Management Tip:** In acute Digoxin poisoning, the degree of **hyperkalemia** is a better predictor of mortality than the digoxin level itself. * **ECG in Hyperkalemia:** Look for tall tented T-waves, PR prolongation, and eventually a "sine wave" pattern. * **Other causes to remember:** Succinylcholine (especially in burn/trauma patients), Beta-blockers, and NSAIDs.

Question 15: A 46-year-old male presented to the emergency with muscle weakness and cramping. He has been taking hydrochlorothiazide for recently diagnosed hypertension. Which of the following is the most likely cause of his symptoms?

A. Hyponatremia
B. Hypokalemia (Correct Answer)
C. Hypoglycemia
D. Hypocalcemia

Explanation: **Explanation:** The patient is presenting with classic symptoms of **Hypokalemia** (muscle weakness and cramping) secondary to the use of **Hydrochlorothiazide (HCTZ)**, a thiazide diuretic. **Why Hypokalemia is correct:** Thiazide diuretics act on the distal convoluted tubule (DCT) by inhibiting the $Na^+/Cl^-$ symporter. This increases the delivery of sodium to the collecting ducts. In response, the body activates the renin-angiotensin-aldosterone system (RAAS), leading to increased sodium reabsorption in exchange for potassium and hydrogen ions. This results in excessive urinary potassium loss. Low serum potassium levels interfere with the resting membrane potential of muscle cells, leading to **muscle weakness, cramps, and potentially cardiac arrhythmias.** **Why other options are incorrect:** * **Hyponatremia:** While thiazides can cause low sodium, it typically presents with neurological symptoms (confusion, seizures, or lethargy) rather than isolated muscle cramping and weakness. * **Hypoglycemia:** Thiazides actually tend to cause **hyperglycemia** (by inhibiting insulin release and decreasing peripheral glucose utilization), not hypoglycemia. * **Hypocalcemia:** This is a common distractor. Thiazides actually cause **Hypercalcemia** because they increase calcium reabsorption in the DCT. (Note: Loop diuretics like Furosemide cause hypocalcemia). **NEET-PG High-Yield Pearls:** * **Thiazide Side Effects (Mnemonic: GLUC):** Hyper**G**lycemia, Hyper**L**ipidemia, Hyper**U**ricemia (can precipitate Gout), and Hyper**C**alcemia. * **Electrolyte Profile:** Hypokalemic metabolic alkalosis. * **Clinical Tip:** Always monitor serum electrolytes and encourage potassium-rich foods (or consider a potassium-sparing diuretic) when a patient starts HCTZ.

Question 16: Immediately after eating, a man develops swelling of face and lips, respiratory distress, intense pruritus, hypotension, and a feeling of impending doom. What is the most likely diagnosis?

A. Angioneurotic Edema
B. Anaphylaxis (Correct Answer)
C. Myocardial Infarction
D. Food stuck in throat

Explanation: **Explanation:** The clinical presentation describes a classic case of **Anaphylaxis**, a severe, life-threatening Type I hypersensitivity reaction (IgE-mediated) [2]. The diagnosis is clinical, characterized by the rapid onset (seconds to minutes) of multisystem involvement following exposure to an allergen (in this case, food) [2]. **Why Anaphylaxis is correct:** The patient exhibits signs across multiple organ systems: * **Cutaneous:** Swelling of face/lips (angioedema) and intense pruritus [1]. * **Respiratory:** Distress (likely due to laryngeal edema or bronchospasm) [1]. * **Cardiovascular:** Hypotension and the "feeling of impending doom" (a classic symptom of distributive shock) [1]. The involvement of **two or more systems** (Skin + Respiratory/CV) or **hypotension** after exposure confirms anaphylaxis over simple allergy. **Why other options are incorrect:** * **Angioneurotic Edema:** While present, it is only a component of the reaction. Isolated angioedema does not typically present with hypotension or systemic "impending doom." * **Myocardial Infarction:** While it causes hypotension and distress, it does not explain the acute pruritus, facial swelling, or the immediate temporal link to eating. * **Food stuck in throat:** This causes mechanical airway obstruction (choking) but would not cause hypotension, generalized pruritus, or lip swelling. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice:** Adrenaline (Epinephrine) **1:1000** concentration given **Intramuscularly (IM)** in the anterolateral thigh [1]. 2. **Mechanism:** Adrenaline acts as a physiological antagonist (Alpha-1: vasoconstriction; Beta-1: inotropy; Beta-2: bronchodilation). 3. **Biphasic Reaction:** Symptoms can recur 1–72 hours after initial resolution; hence, patients must be observed [1]. 4. **Lab Marker:** Serum **Tryptase** levels (measured within 1–3 hours) can retrospectively confirm the diagnosis.

Question 17: Which of the following medications can cause erectile dysfunction?

A. Antihistamines (Correct Answer)
B. Leukotriene antagonists
C. Thyroxine
D. Insulin glargine

Explanation: **Explanation:** **Correct Answer: A. Antihistamines** Erectile dysfunction (ED) is a common side effect of several drug classes, including **Antihistamines** (specifically H1-receptor antagonists like diphenhydramine and promethazine). The underlying mechanism is two-fold: 1. **Anticholinergic Activity:** Many first-generation antihistamines possess significant anticholinergic properties. Penile erection is a parasympathetic-mediated event (via nitric oxide and cGMP); anticholinergics inhibit this parasympathetic outflow, leading to difficulty achieving or maintaining an erection. 2. **Sedative Effects:** Central nervous system depression can decrease libido and arousal. **Analysis of Incorrect Options:** * **B. Leukotriene Antagonists (e.g., Montelukast):** These are primarily associated with neuropsychiatric side effects (mood changes, sleep disturbances) but are not typically linked to erectile dysfunction. * **C. Thyroxine:** Exogenous thyroxine is used to treat hypothyroidism. While *untreated* hypothyroidism or hyperthyroidism can cause sexual dysfunction [1], the replacement therapy itself does not cause ED unless it leads to a state of iatrogenic thyrotoxicosis. * **D. Insulin Glargine:** Insulin is used to manage diabetes mellitus. While diabetes is a leading cause of organic ED due to microvascular and neuropathic damage [1], insulin therapy itself is not the causative agent of ED. **High-Yield Clinical Pearls for NEET-PG:** * **Common Drug Causes of ED:** * **Antihypertensives:** Thiazide diuretics and Beta-blockers (except Nebivolol, which is NO-donating) [2]. * **Antipsychotics:** Due to dopamine antagonism leading to hyperprolactinemia (e.g., Risperidone). * **Antidepressants:** SSRIs (most common cause of delayed ejaculation/decreased libido) [2]. * **Anti-androgens:** Finasteride, Spironolactone, and Ketoconazole [2]. * **Management:** The first-line pharmacological treatment for ED is **PDE-5 Inhibitors** (Sildenafil, Tadalafil), which are contraindicated in patients taking **Nitrates** due to the risk of severe hypotension.

Question 18: HLA-B*1502 is a genetic marker for which of the following conditions?

A. Systemic lupus erythematosus
B. Polyarteritis nodosa
C. Stevens-Johnson syndrome (Correct Answer)
D. Seronegative spondyloarthritis syndrome

Explanation: **Explanation:** The correct answer is **C. Stevens-Johnson syndrome (SJS)**. **HLA-B*1502** is a genetic allele strongly associated with an increased risk of severe cutaneous adverse reactions (SCARs), specifically **Stevens-Johnson syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**, triggered by the use of **Carbamazepine** [1]. This association is most prevalent in populations of Southeast Asian and Han Chinese descent. The HLA molecule likely presents the drug (or its metabolite) to T-cells, initiating a massive cytotoxic immune response against keratinocytes. Due to this strong correlation, the FDA recommends screening for HLA-B*1502 in high-risk populations before initiating Carbamazepine therapy. **Why other options are incorrect:** * **A. Systemic Lupus Erythemetosus (SLE):** SLE is primarily associated with **HLA-DR2** and **HLA-DR3**. Drug-induced lupus is more commonly linked to "slow acetylator" status (NAT2 polymorphism) rather than HLA-B*1502. * **B. Polyarteritis Nodosa (PAN):** PAN is a systemic necrotizing vasculitis often associated with **Hepatitis B** infection; it does not have a specific association with HLA-B*1502. * **D. Seronegative Spondyloarthritis:** This group of disorders (e.g., Ankylosing Spondylitis) is classically associated with **HLA-B27**. **High-Yield Clinical Pearls for NEET-PG:** * **HLA-B*5701:** Associated with hypersensitivity to **Abacavir** (Antiretroviral). * **HLA-B*5801:** Associated with **Allopurinol**-induced SJS/TEN. * **HLA-DR4:** Associated with Rheumatoid Arthritis and Pemphigus Vulgaris. * **HLA-DQ2/DQ8:** Associated with Celiac Disease.

Question 19: A young female presents with severe abdominal pain, constipation, irrelevant talking, a BP of 160/110 mmHg, heart rate of 120/min, fever, and a positive Watson-Schwartz test in urine. Which of the following drugs should not be used in this condition?

A. Sodium Valproate
B. Alcohol
C. Griseofulvin
D. All of the above (Correct Answer)

Explanation: ### Explanation **Diagnosis: Acute Intermittent Porphyria (AIP)** The clinical presentation—**abdominal pain, constipation, neuropsychiatric symptoms** (irrelevant talking), and **autonomic instability** (hypertension, tachycardia, fever)—is the classic "tetrad" of AIP [1]. The **Watson-Schwartz test** confirms the diagnosis by detecting elevated levels of porphobilinogen (PBG) in the urine. **The Underlying Concept: Enzyme Induction** AIP is caused by a deficiency in the enzyme *hydroxymethylbilane synthase* [1]. The condition is exacerbated by any factor that induces **Cytochrome P450 (CYP450)** enzymes. When these enzymes are induced, the demand for "Heme" increases, which upregulates **ALA Synthase** (the rate-limiting enzyme). This leads to a toxic accumulation of porphyrin precursors (ALA and PBG), triggering an acute attack. **Why "All of the Above" is Correct:** All three substances listed are potent **porphyrinogenic agents**: * **Sodium Valproate:** An anticonvulsant that induces hepatic enzymes and is strictly contraindicated in porphyria [1]. * **Alcohol:** A common trigger that induces ALA synthase and interferes with the heme biosynthetic pathway [1]. * **Griseofulvin:** An antifungal drug known to be a potent inducer of CYP450 enzymes, frequently cited in exams as a trigger for AIP. **Clinical Pearls for NEET-PG:** * **The 5 P’s of AIP:** **P**ainful abdomen, **P**olyneuropathy, **P**sychiatric disturbances, **P**ink urine (on standing), and **P**recipitated by drugs [1]. * **Safe Drugs:** If a patient with AIP needs treatment, safe options include **Aspirin, Paracetamol, Morphine, and Gabapentin.** * **Management:** The treatment of choice for an acute attack is **Intravenous Hematin** (which provides negative feedback to ALA synthase) and **High-dose Glucose** (which inhibits ALA synthase transcription).

Question 20: Testing of HLA-B57:07 is recommended prior to the initiation of which of the following anti-retroviral agents?

A. Atazanavir
B. Nelfinavir
C. Raltegravir
D. Abacavir (Correct Answer)

Explanation: **Explanation:** The correct answer is **Abacavir (Option D)**. **1. Why Abacavir is correct:** Abacavir is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in HIV treatment. Its use is strongly associated with a potentially life-threatening **Abacavir Hypersensitivity Reaction (HSR)**. This reaction is a Type IV (delayed) hypersensitivity mediated by T-cells. There is a definitive genetic predisposition: patients carrying the **HLA-B*57:01** allele are at a significantly higher risk (approx. 50%) of developing HSR. Therefore, international guidelines (and NEET-PG high-yield facts) mandate screening for this allele before starting Abacavir. If positive, the drug is contraindicated. **2. Why other options are incorrect:** * **Atazanavir (A):** A Protease Inhibitor (PI) known for causing unconjugated hyperbilirubinemia (jaundice) due to UGT1A1 inhibition, but it does not require HLA testing. * **Nelfinavir (B):** An older PI primarily associated with gastrointestinal side effects (diarrhea). No HLA association exists. * **Raltegravir (C):** An Integrase Strand Transfer Inhibitor (INSTI). While it can cause rare skin rashes or SJS, there is no routine genetic screening required for its initiation. **3. High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation of HSR:** Fever, rash, GI symptoms (nausea/vomiting), and respiratory symptoms (cough/dyspnea) occurring within the first 6 weeks. * **The "Gold Standard" Rule:** Never "re-challenge" a patient with Abacavir if HSR is suspected; it can lead to fatal anaphylaxis. * **Other HLA-Drug Associations:** * **HLA-B*15:02:** Carbamazepine (SJS/TEN risk in Asians). * **HLA-B*58:01:** Allopurinol (Severe cutaneous adverse reactions). * **HLA-DQB1*06:02:** Clozapine (Agranulocytosis).

Question 21: Antibiotic prophylaxis is indicated in which of the following procedures?

A. Cardiac catheterisation
B. Prostatectomy
C. Cystoscopy
D. Dental procedures (Correct Answer)

Explanation: Explanation: The primary goal of antibiotic prophylaxis in clinical practice is to prevent **Infective Endocarditis (IE)** in high-risk patients or to prevent surgical site infections. [1] **1. Why Dental Procedures are correct:** Dental procedures involving manipulation of gingival tissue, the periapical region of teeth, or perforation of the oral mucosa (e.g., extractions, scaling) are notorious for causing transient bacteremia, typically with *Viridans group streptococci*. According to current AHA/IDSA guidelines, prophylaxis is indicated for these procedures **only in high-risk patients** (e.g., prosthetic heart valves, previous IE, or certain congenital heart diseases). **2. Why the other options are incorrect:** * **Cardiac Catheterization (A):** This is a clean vascular procedure. The risk of bacteremia is extremely low (<1%), and routine prophylaxis is not recommended. * **Prostatectomy (B) & Cystoscopy (C):** While these are urological procedures, routine IE prophylaxis is no longer recommended by modern guidelines unless there is an active infection. If the patient has a documented UTI, the infection should be treated before the procedure; otherwise, the risk of IE from sterile urologic manipulation is negligible. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Oral **Amoxicillin (2g)** given 30–60 minutes before the procedure. * **If Penicillin allergic:** Use **Clindamycin (600mg)**, Azithromycin, or Cephalexin. * **High-Risk Conditions requiring IE prophylaxis:** 1. Prosthetic heart valves (including TAVI). 2. Prior history of Infective Endocarditis. 3. Unrepaired cyanotic congenital heart disease. 4. Cardiac transplant recipients with valve regurgitation. [1] * **Prophylaxis is NOT indicated for:** Routine anesthetic injections, X-rays, shedding of primary teeth, or simple GI endoscopies.

Question 22: All of the following are physiological responses to smoking, EXCEPT:

A. Decreased HDL
B. Increased hematocrit
C. Increased heart rate and increased catecholamine release
D. Decreased carboxyhemoglobin (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Decreased carboxyhemoglobin**. Smoking actually causes an **increase** in carboxyhemoglobin levels, not a decrease. **1. Why Option D is the Correct Answer:** Cigarette smoke contains **carbon monoxide (CO)**, which has an affinity for hemoglobin that is 200–250 times greater than that of oxygen [1]. When inhaled, CO binds to hemoglobin to form **carboxyhemoglobin (COHb)**. This shifts the oxygen-dissociation curve to the left, reducing oxygen delivery to tissues [1], [2]. Chronic smokers typically have COHb levels between 5–10%, compared to <1% in non-smokers. **2. Why the other options are incorrect (Physiological responses to smoking):** * **A. Decreased HDL:** Smoking modifies lipid metabolism, leading to a pro-atherogenic profile characterized by decreased High-Density Lipoprotein (HDL) and increased LDL and triglycerides. * **B. Increased hematocrit:** To compensate for the chronic tissue hypoxia caused by elevated carboxyhemoglobin, the kidneys increase **erythropoietin** production. This results in secondary polycythemia (increased hematocrit). * **C. Increased heart rate and catecholamine release:** Nicotine stimulates the sympathetic nervous system and the adrenal medulla, leading to the release of **epinephrine and norepinephrine**. This acutely increases heart rate, blood pressure, and myocardial contractility. **High-Yield Clinical Pearls for NEET-PG:** * **Smoking and Surgery:** Patients are advised to stop smoking at least **6–8 weeks** before surgery to reduce pulmonary complications and improve wound healing. * **Drug Interactions:** Smoking **induces CYP1A2**. This can lead to decreased serum levels of drugs like **Theophylline** and **Clozapine**. * **Buerger’s Disease (Thromboangiitis Obliterans):** A non-atherosclerotic inflammatory disease strongly associated with heavy smoking; the primary treatment is absolute smoking cessation.

Question 23: A 60-year-old male presents with muscle pain, fatigue, and dark urine. His medical history includes stable angina, and his current medications are atenolol, atorvastatin, and aspirin. Urine dipstick is positive for blood, but microscopy reveals no RBCs. Serum creatinine kinase is significantly elevated. Which of the following medication additions is most likely to have precipitated this patient's condition?

A. Erythromycin (Correct Answer)
B. Rifampin
C. Griseofulvin
D. Amikacin

Explanation: ### Explanation **Correct Answer: A. Erythromycin** **Mechanism & Concept:** The patient is presenting with **Statin-induced Rhabdomyolysis**, characterized by the triad of muscle pain, elevated Creatine Kinase (CK), and myoglobinuria (positive dipstick for blood but negative microscopy for RBCs). [1] Atorvastatin is metabolized by the **Cytochrome P450 3A4 (CYP3A4)** enzyme system. **Erythromycin** is a potent **CYP3A4 inhibitor**. When added to a stable statin regimen, erythromycin inhibits the metabolism of atorvastatin, leading to toxic plasma levels of the drug [1]. This increases the risk of skeletal muscle toxicity, ranging from mild myalgia to life-threatening rhabdomyolysis and acute kidney injury. **Analysis of Incorrect Options:** * **B. Rifampin:** This is a potent **CYP450 inducer**. It would increase the metabolism of atorvastatin, thereby *decreasing* its plasma concentration and efficacy, rather than causing toxicity. * **C. Griseofulvin:** This is also a **CYP450 inducer** (though less potent than Rifampin). It would not precipitate statin toxicity. * **D. Amikacin:** An aminoglycoside known for nephrotoxicity and ototoxicity, but it does not interact with the CYP3A4 system or increase the risk of statin-induced myopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Common CYP3A4 Inhibitors (The "Statin-Killers"):** Macrolides (Erythromycin, Clarithromycin), Azole antifungals (Ketoconazole), Protease inhibitors (Ritonavir), and Grapefruit juice. * **Safe Alternatives:** If a macrolide is necessary, **Azithromycin** is preferred as it does not significantly inhibit CYP3A4. * **Statin Metabolism:** Atorvastatin, Lovastatin, and Simvastatin are CYP3A4 substrates [1]. **Pravastatin** and **Rosuvastatin** are not significantly metabolized by CYP3A4 and carry a lower risk of these specific drug interactions. [1] * **Diagnostic Clue:** "Heme positive, RBC negative" urine always suggests Myoglobinuria (Rhabdomyolysis) or Hemoglobinuria (Hemolysis).

Question 24: For a patient undergoing anticoagulant therapy who requires unavoidable dental surgical treatment, what should the dental surgeon do?

A. Not undertake the procedure until the anticoagulant therapy is completed.
B. Reduce the dosage of anticoagulant and proceed with the procedure.
C. Adjust the dosage before and after the dental visit.
D. Consult the patient's physician for a joint decision. (Correct Answer)

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The management of a patient on anticoagulants (like Warfarin or DOACs) requires a delicate balance between the **risk of thromboembolism** (if the drug is stopped) and the **risk of post-operative hemorrhage** (if the drug is continued) [1]. Because the underlying indication for anticoagulation (e.g., prosthetic heart valves, atrial fibrillation, or recent DVT) varies in severity, the dental surgeon cannot unilaterally alter the regimen. A **multidisciplinary approach** involving the patient’s physician/cardiologist is essential to assess the patient's specific thromboembolic risk profile and determine if bridging therapy or temporary cessation is required. **2. Why the Other Options are Wrong:** * **Option A:** Delaying treatment until therapy is completed is often impossible, as many patients are on lifelong anticoagulation. Delaying urgent dental surgery can lead to systemic infection or worsening pain. * **Option B & C:** Adjusting or reducing the dosage independently by the dentist is dangerous. For example, sub-therapeutic levels of warfarin in a patient with a mechanical heart valve can lead to fatal valve thrombosis [1]. Any dose modification must be supervised by the prescribing physician. **3. High-Yield Clinical Pearls for NEET-PG:** * **INR Guidelines:** For most minor dental procedures (extractions, scaling), if the **INR is < 3.5**, the procedure can usually proceed without stopping Warfarin, using local hemostatic agents (e.g., tranexamic acid mouthwash, oxidized cellulose) [1]. * **Bridging Therapy:** High-risk patients (e.g., those with mechanical valves) may require "bridging" with Heparin (LMWH) if Warfarin must be stopped [1]. * **DOACs:** For Direct Oral Anticoagulants (Rivaroxaban, Apixaban), the timing of the procedure is usually planned just before the next dose is due to ensure the lowest plasma concentration.

Question 25: A 40-year-old male patient presented with a characteristic facial rash, fever, arthralgia, and moderate chest pain. He reported using a certain drug for 3 months. On examination, there was no central nervous system involvement. Laboratory findings revealed normal urine routine microscopy and normal renal function tests. Antinuclear antibody (ANA) and anti-histone antibody titers were elevated. Which of the following mechanisms is most likely implicated in this condition?

A. Drug-induced hypersensitivity reaction
B. Autoimmune reaction mediated by cytotoxic T cells
C. Immune complex deposition in blood vessels
D. Formation of autoantibodies against nuclear antigens due to drug interaction (Correct Answer)

Explanation: ### Explanation The clinical presentation of a facial rash, fever, arthralgia, and pleuritic chest pain (suggestive of serositis) in a patient taking a long-term medication points toward **Drug-Induced Lupus Erythematosus (DILE)**. **1. Why the Correct Answer is Right:** DILE is characterized by the **formation of autoantibodies against nuclear antigens** (specifically histones) triggered by certain drugs [1]. Unlike systemic lupus erythematosus (SLE), DILE typically spares the CNS and kidneys (explaining the normal urine microscopy and renal function). The hallmark laboratory finding is the presence of **Anti-histone antibodies** (positive in >95% of cases) and a positive **ANA**. The mechanism involves the drug or its metabolites acting as haptens or altering the epigenetic methylation of T cells, leading to the loss of self-tolerance and the production of autoantibodies. **2. Why Other Options are Wrong:** * **Option A:** Drug-induced hypersensitivity (like DRESS syndrome) usually presents with eosinophilia, lymphadenopathy, and organ dysfunction (liver/kidney), rather than specific anti-histone antibodies. * **Option B:** While T cells are involved in the loss of tolerance, the primary diagnostic and pathogenic feature of DILE is the B-cell mediated production of autoantibodies. * **Option C:** Immune complex deposition (Type III hypersensitivity) is the mechanism for *Serum Sickness* or the systemic manifestations of *SLE*, but the question specifically asks for the mechanism implicated in the *formation* of the condition described (autoantibody production). **3. High-Yield Facts for NEET-PG:** * **Common Culprits (SHIPP):** **S**ulfonamides, **H**ydralazine (highest risk), **I**soniazid, **P**rocainamide (highest risk), **P**henytoin. * **Key Markers:** Anti-histone antibodies (Most specific for DILE); Anti-dsDNA is usually **negative** (unlike SLE). * **Genetic Predisposition:** More common in **slow acetylators** (due to the role of the N-acetyltransferase enzyme in drug metabolism). * **Management:** Symptoms usually resolve within weeks of **discontinuing the offending drug**.

Question 26: Which of the following medications is an inhibitor of angiotensin-converting enzyme (ACE)?

A. hydralazine
B. enalapril (Correct Answer)
C. spironolactone
D. metoprolol

Explanation: **Explanation:** **Enalapril** is the correct answer as it belongs to the **Angiotensin-Converting Enzyme (ACE) Inhibitors** class. These drugs work by inhibiting the enzyme responsible for converting Angiotensin I to Angiotensin II (a potent vasoconstrictor) and by preventing the breakdown of bradykinin [1]. This results in systemic vasodilation and decreased aldosterone secretion, making them first-line agents for hypertension, heart failure, and diabetic nephropathy [2]. **Analysis of Incorrect Options:** * **A. Hydralazine:** A direct-acting **arteriolar vasodilator**. It is primarily used in hypertensive emergencies in pregnancy or in combination with nitrates for heart failure in specific populations. * **C. Spironolactone:** A **potassium-sparing diuretic** that acts as a competitive antagonist at the mineralocorticoid (aldosterone) receptor in the distal renal tubules. * **D. Metoprolol:** A **selective Beta-1 adrenergic blocker** (cardioselective). It reduces blood pressure and heart rate by decreasing cardiac output and renin release. **High-Yield Clinical Pearls for NEET-PG:** * **Suffix Recognition:** ACE inhibitors typically end in **"-pril"** (e.g., Lisinopril, Ramipril) [1]. * **Side Effects:** The most common side effect is a **dry cough** (due to increased bradykinin levels) [3]. A more severe but rare side effect is **angioedema** [1]. * **Teratogenicity:** ACE inhibitors are strictly **contraindicated in pregnancy** as they cause fetal renal dysgenesis (teratogenic). * **Metabolism:** Most ACE inhibitors are **prodrugs** (e.g., Enalapril is converted to Enalaprilat), except for **Lisinopril and Captopril**, which are active drugs.

Question 27: All the following are complications of streptokinase, except?

A. Joint pain (Correct Answer)
B. Intracranial bleed
C. Anaphylaxis
D. Hypotension

Explanation: Streptokinase is a first-generation fibrinolytic agent derived from *Beta-hemolytic Streptococci* [1]. Understanding its mechanism and side-effect profile is crucial for NEET-PG. **Why Joint Pain is the Correct Answer:** Joint pain (arthralgia) is **not** a recognized or typical complication of streptokinase therapy. While streptokinase is highly immunogenic, its allergic manifestations usually present as skin rashes, urticaria, or systemic anaphylaxis rather than isolated joint involvement. **Analysis of Incorrect Options:** * **Intracranial Bleed:** This is the most feared complication of all thrombolytic agents. By activating plasminogen to plasmin systemically, streptokinase creates a "lytic state," significantly increasing the risk of hemorrhagic stroke [1], [3]. * **Anaphylaxis:** Since streptokinase is a bacterial protein (non-human source), it is highly antigenic [1], [3]. Patients may develop Type I hypersensitivity reactions, ranging from mild rashes to fatal anaphylactic shock. This is why it cannot be readministered within 6–12 months due to high antistreptococcal antibody titers. * **Hypotension:** This is a common side effect unique to streptokinase (not seen with Alteplase). It is often infusion-rate dependent and is thought to be mediated by the release of bradykinin. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** It is a non-specific plasminogen activator [1], [2]; it binds to plasminogen to form an active complex that converts free plasminogen into plasmin. * **Half-life:** Approximately 20 minutes. * **Contraindication:** Previous streptococcal infection or prior streptokinase use (due to neutralizing antibodies) [3]. * **Management of Bleeding:** If life-threatening bleeding occurs, the antidote is **Epsilon-aminocaproic acid** or **Tranexamic acid**.

Question 28: Which of the following statements about Histamine is true?

A. Is found in Mast cells
B. Increases gastric acid secretion
C. Related to arousal and blood pressure
D. All of the above (Correct Answer)

Explanation: Histamine is a biogenic amine that acts as a critical mediator in inflammation, gastric physiology, and neurotransmission [1]. The correct answer is **D (All of the above)** because histamine exerts diverse physiological effects through four distinct G-protein coupled receptors ($H_1$ to $H_4$). **Breakdown of Options:** * **Option A (Mast Cells):** Histamine is primarily synthesized and stored in the granules of **mast cells** and **basophils** [1]. Upon IgE-mediated sensitization and subsequent antigen exposure, these cells degranulate, releasing histamine into the systemic circulation (Type I Hypersensitivity). * **Option B (Gastric Acid):** Histamine is released from **Enterochromaffin-like (ECL) cells** in the stomach [1]. It acts on **$H_2$ receptors** located on gastric parietal cells, stimulating the proton pump to increase gastric acid secretion [1]. This is the physiological basis for using $H_2$ blockers (e.g., Famotidine) in peptic ulcer disease. * **Option C (Arousal and BP):** In the CNS, histaminergic neurons in the **tuberomammillary nucleus** of the hypothalamus regulate wakefulness and arousal (explaining why first-generation antihistamines cause sedation) [1]. Peripherally, histamine causes vasodilation via $H_1$ and $H_2$ receptors, leading to a **decrease in blood pressure** and contributing to the pathophysiology of anaphylactic shock. **High-Yield Clinical Pearls for NEET-PG:** * **Triple Response of Lewis:** Characterized by Red spot (vasodilation), Wheal (exudation), and Flare (axonal reflex). * **Receptor Specificity:** $H_1$ (Allergy/Smooth muscle), $H_2$ (Gastric acid), $H_3$ (Presynaptic/CNS), $H_4$ (Chemotaxis) [1]. * **Drug of Choice:** Adrenaline (1:1000 IM) is the physiological antagonist of histamine and the drug of choice for anaphylaxis.

Question 29: What is the concentration of potassium in Ringer Lactate solution?

A. 1 mEq/L
B. 4 mEq/L (Correct Answer)
C. 2 mEq/L
D. 6 mEq/L

Explanation: ### Explanation Ringer’s Lactate (RL), also known as Hartmann's solution, is a balanced crystalloid solution designed to closely mimic the electrolyte composition of human plasma [1]. It is the fluid of choice for resuscitation in trauma, burns, and intraoperative fluid replacement. **Why Option B is Correct:** The concentration of **Potassium (K+) in Ringer’s Lactate is 4 mEq/L**. This concentration is intentionally set to match the normal physiological range of potassium in human extracellular fluid (3.5–5.0 mEq/L). This makes RL "iso-kalemic," reducing the risk of significant electrolyte shifts during large-volume resuscitation compared to Normal Saline (0.9% NaCl), which contains no potassium. **Analysis of Incorrect Options:** * **Option A (1 mEq/L) & C (2 mEq/L):** These concentrations are too low to maintain physiological homeostasis and do not represent any standard balanced crystalloid. * **Option D (6 mEq/L):** This exceeds the normal plasma range. Administering a fluid with 6 mEq/L of potassium could potentially worsen hyperkalemia, especially in patients with renal compromise. **High-Yield Clinical Pearls for NEET-PG:** * **Composition of RL (per Liter):** Na+ (130–131 mEq), Cl- (109–111 mEq), Lactate (28–29 mEq), K+ (4 mEq), and Ca2+ (3 mEq) [1]. * **Osmolarity:** RL is slightly hypotonic (approx. 273 mOsm/L) compared to plasma (285–295 mOsm/L). * **Metabolism:** The lactate in RL is converted by the **liver** into bicarbonate, making it useful in treating metabolic acidosis. * **Contraindications:** Avoid RL in patients receiving blood transfusions (Calcium can cause clotting in the tubing if Citrate is present) and in patients with severe liver disease (inability to metabolize lactate).

Question 30: Which of the following is given to prevent methotrexate toxicity?

A. MESNA
B. Flumazenil
C. Fomipezole
D. Calcium leucovorin (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Calcium leucovorin** **Mechanism of Action:** Methotrexate (MTX) is a cytotoxic antimetabolite that inhibits the enzyme **Dihydrofolate Reductase (DHFR)** [1]. This inhibition prevents the conversion of dihydrofolate to tetrahydrofolate (THF), the active form of folic acid required for DNA synthesis. **Calcium Leucovorin** (also known as Folinic Acid) is a reduced form of folate. It does not require DHFR for activation; instead, it bypasses the metabolic block created by MTX, providing a source of THF for healthy cells. This process is clinically termed **"Leucovorin Rescue,"** and it is administered 24 hours after high-dose MTX [1] to prevent bone marrow suppression and GI toxicity. **Analysis of Incorrect Options:** * **A. MESNA:** Used to prevent **hemorrhagic cystitis** caused by Acrolein, a toxic metabolite of Cyclophosphamide and Ifosfamide. * **B. Flumazenil:** A competitive benzodiazepine receptor antagonist used to reverse **Benzodiazepine overdose**. * **C. Fomepizole:** An inhibitor of alcohol dehydrogenase used as an antidote for **Methanol or Ethylene glycol poisoning** [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Glucarpidase:** An alternative agent used in MTX toxicity (especially in renal failure) that directly degrades MTX into inactive metabolites. * **Vincristine Interaction:** Leucovorin should **not** be confused with the treatment for Vincristine overdose (which is managed with Hyaluronidase and warm compresses). * **Potentiation:** While Leucovorin "rescues" cells from MTX, it actually **potentiates** the activity of **5-Fluorouracil (5-FU)** by stabilizing its binding to thymidylate synthase.

Question 31: Coloured urine is not seen in which of the following medications?

A. Quinine (Correct Answer)
B. Rifampicin
C. Nitrofurantoin
D. Pyridium

Explanation: The correct answer is **Quinine**. Quinine is an alkaloid used in the treatment of malaria; while it can cause significant side effects like Cinchonism, it does **not** typically cause discoloration of the urine [1]. However, it is important to distinguish this from "Blackwater Fever" (massive intravascular hemolysis caused by *P. falciparum*), where the urine turns dark/black due to hemoglobinuria, not the drug itself. **Analysis of Incorrect Options:** * **Rifampicin:** A classic NEET-PG favorite. It causes a harmless **orange-red** discoloration of urine, sweat, tears, and saliva. Patients must be counseled about this to prevent poor compliance. * **Nitrofurantoin:** Used primarily for UTIs, this drug commonly causes the urine to turn **brown or dark yellow**. * **Pyridium (Phenazopyridine):** A urinary analgesic used for symptomatic relief of cystitis. It characteristically causes a bright **orange to reddish** discoloration of the urine. **High-Yield Clinical Pearls for NEET-PG:** * **Red/Orange Urine:** Rifampicin, Phenazopyridine, Anthracyclines (Doxorubicin), Senna (laxative). * **Brown/Black Urine:** Nitrofurantoin, Metronidazole, L-Dopa, Alkaptonuria (on standing), Methocarbamol. * **Blue/Green Urine:** Amitriptyline, Methylene blue, Propofol, Triamterene, Pseudomonas infection. * **Milky White (Chyluria):** Wuchereria bancrofti (Filariasis). Understanding drug-induced urine discoloration is vital for differentiating pharmacological side effects from pathological conditions like hematuria or myoglobinuria.

Question 32: Sulfasalazine is NOT used for the treatment of which of the following conditions?

A. Crohn's disease
B. Rheumatoid arthritis
C. Sarcoidosis (Correct Answer)
D. Ulcerative colitis

Explanation: **Explanation:** Sulfasalazine is a prodrug consisting of **5-aminosalicylic acid (5-ASA)** linked to **sulfapyridine** by a covalent azo bond. Its therapeutic utility is primarily derived from its anti-inflammatory and immunomodulatory properties. **Why Sarcoidosis is the Correct Answer:** Sarcoidosis is a multisystem granulomatous disease [2]. The mainstay of treatment for symptomatic sarcoidosis is **Corticosteroids** (e.g., Prednisolone). In steroid-resistant cases, second-line agents include Methotrexate, Azathioprine, or TNF-alpha inhibitors (Infliximab). Sulfasalazine has no established role in the management of sarcoidosis. **Analysis of Other Options:** * **Ulcerative Colitis (UC):** Sulfasalazine is a classic first-line agent for inducing and maintaining remission in mild-to-moderate UC [1]. The azo bond is cleaved by colonic bacteria, releasing 5-ASA (Mesalamine) directly at the site of colonic inflammation [1]. * **Crohn’s Disease:** While less effective than in UC (due to the transmural nature of Crohn's), Sulfasalazine is used for colonic involvement in Crohn’s disease [1]. * **Rheumatoid Arthritis (RA):** Sulfasalazine is classified as a **DMARD** (Disease-Modifying Anti-Rheumatic Drug). In RA, the sulfapyridine moiety is thought to be the active component responsible for systemic immunomodulation. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits prostaglandin synthesis and leukotriene production. * **Side Effects:** Reversible **oligospermia** (common MCQ), megaloblastic anemia (due to folate deficiency—always supplement folic acid), and hypersensitivity reactions (Stevens-Johnson Syndrome). * **Metabolism:** Acetylation in the liver. "Slow acetylators" are at a higher risk of toxicity. * **Monitoring:** Baseline and periodic CBC and LFTs are required.

Question 33: Coloured urine is not seen in which of the following medications?

A. Quinine (Correct Answer)
B. Rifampicin
C. Nitrofurantoin
D. Pyridium

Explanation: The correct answer is **Quinine**. [1] **1. Why Quinine is the correct answer:** Quinine, an alkaloid used in the treatment of malaria, does not typically cause discoloration of the urine as a direct pharmacological effect [1]. However, it is famously associated with **"Blackwater Fever"** (massive intravascular hemolysis in *P. falciparum* malaria), which leads to hemoglobinuria (dark/black urine) [2]. In this context, the color change is a result of a pathological complication (hemolysis), not a direct property of the drug itself. **2. Analysis of Incorrect Options:** * **Rifampicin:** A classic high-yield fact. It causes a harmless **orange-red** discoloration of urine, sweat, tears, and saliva. Patients must be counseled about this to prevent poor compliance. * **Nitrofurantoin:** This urinary antiseptic commonly causes the urine to turn **brown or dark yellow**. * **Pyridium (Phenazopyridine):** Used as a urinary analgesic for cystitis, it characteristically turns urine a bright **orange to reddish-orange**. It can also stain contact lenses. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Red/Orange Urine:** Rifampicin, Phenazopyridine, Anthracyclines (Doxorubicin), Laxatives (Senna/Phenolphthalein). * **Brown/Black Urine:** Nitrofurantoin, Metronidazole, L-Dopa, Methyldopa, Chloroquine, Alkaptonuria (on standing). * **Blue/Green Urine:** Methylene blue, Amitriptyline, Propofol, Triamterene, Pseudomonas infection. * **Milky White Urine:** Chyluria (Filariasis), Phosphaturia. **Key Takeaway:** Always distinguish between a drug's direct pigmentary effect (Rifampicin) and a pathological complication (Quinine-induced hemolysis).

Question 34: Coloured urine is not seen in which of the following medications?

A. Quinine (Correct Answer)
B. Rifampicin
C. Nitrofurantoin
D. Pyridium

Explanation: **Explanation:** The correct answer is **Quinine (Option A)**. Quinine is an antimalarial drug that does not typically cause discoloration of the urine. While it is associated with "Blackwater Fever" (massive intravascular hemolysis leading to hemoglobinuria), this is a complication of *Plasmodium falciparum* infection rather than a direct pharmacological property of the drug itself [1]. **Analysis of Options:** * **Rifampicin (Option B):** This is a classic high-yield fact. Rifampicin is a potent inducer of microsomal enzymes and characteristically causes **orange-red** discoloration of urine, sweat, tears, and saliva. Patients must be counseled about this to prevent unnecessary alarm. * **Nitrofurantoin (Option C):** Used primarily for UTIs, this drug commonly causes the urine to turn **brown or dark yellow**. * **Pyridium (Phenazopyridine) (Option D):** This is a urinary analgesic used to relieve dysuria. It is notorious for causing a bright **orange to reddish** discoloration of the urine, which can even stain clothing or contact lenses. **Clinical Pearls for NEET-PG:** * **Red/Orange Urine:** Rifampicin, Phenazopyridine, Anthracyclines (Doxorubicin), Laxatives (Senna/Phenolphthalein). * **Brown/Black Urine:** Nitrofurantoin, Metronidazole, L-Dopa, Chloroquine, Alkaptonuria (on standing). * **Blue/Green Urine:** Methylene blue, Amitriptyline, Propofol, Triamterene. * **Milky Urine (Chyluria):** Wuchereria bancrofti (Filariasis). Understanding drug-induced urine discoloration is essential for differentiating pharmacological side effects from pathological conditions like hematuria or myoglobinuria.

Question 35: Which drug is preferred for management of diabetes in a patient with cardiac and renal failure?

A. Pioglitazone
B. Metformin
C. SGLT2 inhibitors (Correct Answer)
D. Sulfonylureas

Explanation: ***SGLT2 inhibitors*** - These agents are strongly recommended due to their proven benefits in reducing **heart failure (HF)** hospitalizations and **cardiovascular (CV) mortality**. - They also offer robust **reno-protection**, slowing the decline of **eGFR** and reducing albuminuria, making them ideal when both cardiac and renal failure coexist. *Pioglitazone* - This drug class (**thiazolidinediones**) is known to cause **fluid retention** and peripheral edema, thus potentially exacerbating or precipitating **congestive heart failure (CHF)**; it is therefore generally avoided [1]. - It is not associated with improved long-term renal or cardiovascular outcomes in the way that SGLT2 inhibitors are. *Metformin* - While a foundational drug, Metformin is contraindicated in severe **renal failure** (e.g., eGFR <30 mL/min/1.73m²) due to the increased risk of potentially fatal **lactic acidosis**. - Although safe in mild to moderate CKD, it lacks the specific, compelling evidence for reducing progression of **heart failure** or **CKD** compared to SGLT2 inhibitors. *Sulfonylureas* - These drugs primarily increase the risk of **hypoglycemia**, which is heightened in patients with **renal insufficiency** due to altered drug metabolism and clearance. - They provide no demonstrated **cardiovascular** or **renal protective benefits** and may be associated with weight gain.

Question 36: For a 40 year old hypertensive woman, which one of the following is not recommended for contraception?

A. IUCD
B. NuvaRing (Correct Answer)
C. Minipill
D. LNG IUD (LNg IUD)

Explanation: ***NuvaRing*** - **NuvaRing** is a **combined hormonal contraceptive** that releases both estrogen and progestin. - **Estrogen-containing contraception** is generally **contraindicated** or used with caution in women with uncontrolled hypertension due to an increased risk of **cardiovascular events** such as stroke and myocardial infarction. *IUCD* - **Intrauterine contraceptive devices (IUCDs)**, both copper and levonorgestrel-releasing, are considered **safe** and highly effective for women with hypertension. - They do not contain systemic hormones or contain only progestin, which has a minimal impact on blood pressure. *Minipill* - The **minipill** is a **progestin-only oral contraceptive**. - **Progestin-only contraceptives** are safe for women with hypertension as they do not carry the same cardiovascular risks associated with estrogen. *LNG IUD (LNg IUD)* - The **levonorgestrel-releasing intrauterine device (LNG IUD)** is a **progestin-only contraceptive**. - It is **safe** for women with hypertension because the progestin is primarily local, and it does not contain estrogen, thereby avoiding cardiovascular risks.

Question 37: The initial prevention strategy for antiphospholipid syndrome will be: 1. Steroids 2. Heparin 3. Low dose aspirin 4. Progesterone support Which of the above is/are correct?

A. 1 and 4
B. 3 only
C. 3 and 4
D. 2 and 3 (Correct Answer)

Explanation: ***2 and 3*** - For pregnant women with antiphospholipid syndrome (APS), a combination of **low-dose aspirin** and **low molecular weight heparin (LMWH)** or **unfractionated heparin (UFH)** is the most widely accepted and effective initial prevention strategy to prevent pregnancy complications. - **Low-dose aspirin** helps reduce platelet aggregation, while **heparin** inhibits coagulation, addressing both thrombotic tendencies associated with APS. *1 and 4* - **Steroids** are typically reserved for severe manifestations of APS, such as catastrophic APS or refractory cases, and are not part of the initial standard preventative regimen. - **Progesterone support** is indicated for threatened miscarriage or luteal phase defect but does not address the underlying thrombotic risk in APS for pregnancy prevention. *3 only* - While **low-dose aspirin** is an important component, it is insufficient on its own for preventing pregnancy complications in women with antiphospholipid syndrome due to the high thrombotic risk. - **Heparin**, either LMWH or UFH, is crucial to provide adequate anticoagulation and is always used in conjunction with aspirin for initial prevention. *3 and 4* - **Low-dose aspirin** is appropriate, but **progesterone support** (4) is not a primary measure for preventing thrombotic events or pregnancy complications specifically linked to antiphospholipid syndrome. - The critical missing component in this option is **heparin**, which is essential for anticoagulation in APS pregnancies.

Question 38: A 66-year-old woman presents to the emergency department after a fall 4 hours ago. She was on her way to the bathroom when she fell to the ground and lost consciousness. Although she regained consciousness within one minute, she experienced lightheadedness for almost half an hour. She has experienced on-and-off dizziness for the past 2 weeks whenever she tries to stand. She has a history of type 2 diabetes mellitus, hypertension, hypercholesterolemia, and chronic kidney disease secondary to polycystic kidneys. Her medications include aspirin, bisoprolol, doxazosin, erythropoietin, insulin, rosuvastatin, and calcium and vitamin D supplements. She has a blood pressure of 111/74 mm Hg while supine and 84/60 mm Hg on standing, the heart rate of 48/min, the respiratory rate of 14/min, and the temperature of 37.0°C (98.6°F). CT scan of the head is unremarkable. Electrocardiogram reveals a PR interval of 250 ms. What is the next best step in the management of this patient?

A. Tilt table testing
B. Holter monitoring
C. Stop antihypertensive medicines (Correct Answer)
D. Electroencephalogram
E. Start anti-epileptics

Explanation: ***Stop antihypertensive medicines*** - The patient exhibits significant **orthostatic hypotension** (systolic drop of 27 mm Hg and diastolic drop of 14 mm Hg, along with lightheadedness lasting 30 minutes) [1] and **bradycardia** (48/min), suggesting that her antihypertensive medications, particularly **doxazosin** (an alpha-blocker causing vasodilation) and **bisoprolol** (a beta-blocker causing bradycardia), are contributing to her symptoms [4]. - Given her fall, lightheadedness, and profound orthostatic changes, immediately reducing or discontinuing the medications causing hypotension and bradycardia is the priority to stabilize her blood pressure and heart rate, preventing further syncopal episodes or falls [1], [4]. *Tilt table testing* - This test is primarily used to diagnose **vasovagal syncope** or **postural orthostatic tachycardia syndrome (POTS)**, often when routine orthostatic measurements are equivocal or other causes have been ruled out [2]. - In this case, the patient's orthostatic hypotension is clearly documented with current medications, and the immediate concern is medication-induced, making further diagnostic testing for this specific cause less urgent than medication adjustment. *Holter monitoring* - **Holter monitoring** is useful for detecting intermittent **cardiac arrhythmias** that may cause syncope. - While the patient has a prolonged PR interval (250 ms) indicating first-degree AV block, which rarely causes syncope on its own, her primary issue appears to be profound orthostatic hypotension [2] and bradycardia likely exacerbated by medications, rather than an uncaptured paroxysmal arrhythmia. *Electroencephalogram* - An **EEG** is indicated to diagnose **seizures** as a cause of loss of consciousness. - The patient's fall and brief loss of consciousness followed by lightheadedness align with syncope rather than a seizure [3]; her CT scan is unremarkable, and there are no typical seizure features (e.g., tonic-clonic movements, postictal confusion, tongue biting) [3]. *Start anti-epileptics* - Starting **anti-epileptics** would only be appropriate if there was strong evidence of a seizure disorder, such as clear clinical presentation of seizure or abnormal EEG findings. - There is no clinical or imaging evidence to support a seizure diagnosis in this patient; her symptoms are more consistent with cardiovascular causes, specifically medication-induced syncope [3].

Question 39: A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

A. Initial administration of allopurinol
B. Initial administration of glucocorticoids
C. Monitoring of drug levels
D. Adequate initial hydration (Correct Answer)
E. Obtaining a thorough history of patient allergies

Explanation: Adequate initial hydration - Intravenous (IV) acyclovir is associated with **nephrotoxicity** due to the formation of **insoluble acyclovir crystals** in the renal tubules, especially in states of dehydration. - **Maintaining adequate hydration** helps in diluting the drug and preventing crystal precipitation, thereby protecting renal function. [1] *Initial administration of allopurinol* - **Allopurinol** is used to prevent **uric acid nephropathy**, typically seen in **tumor lysis syndrome**, not acyclovir-induced crystal nephropathy. [2] - Its administration would not have prevented the formation of **acyclovir crystals**. *Initial administration of glucocorticoids* - **Glucocorticoids** are potent anti-inflammatory agents but do not prevent **drug-induced crystal formation** or directly protect against acyclovir nephrotoxicity. - They are primarily used for inflammatory conditions or to suppress immune responses. *Monitoring of drug levels* - While drug level monitoring can be useful for certain medications to prevent toxicity, it's not the primary preventative measure for **acyclovir-induced crystal nephropathy**. - **Hydration** is more immediate and effective in preventing crystal precipitation. *Obtaining a thorough history of patient allergies* - An allergy history is crucial for preventing **hypersensitivity reactions** to medications, but it would not prevent **nephrotoxicity** due to crystal formation, which is a pharmacokinetic phenomenon. - The patient's renal deterioration is due to **acyclovir crystal nephropathy**, not an allergic reaction.

Question 40: The contraceptive which is contraindicated in DVT is?

A. Barrier method
B. Non hormonal IUCD
C. Billing's method
D. OCP (Correct Answer)

Explanation: ***OCP*** - **Oral contraceptive pills (OCPs)**, especially those containing estrogen, increase the risk of **venous thromboembolism (VTE)**, including deep vein thrombosis (DVT). - Estrogen promotes a **hypercoagulable state** by increasing clotting factors and decreasing natural anticoagulants. *Barrier method* - **Barrier methods** like condoms or diaphragms are non-hormonal and act physically to prevent sperm from reaching the egg. - They have **no systemic effects** on coagulation and are safe for individuals with DVT. *Non hormonal IUCD* - **Non-hormonal intrauterine contraceptive devices (IUCDs)**, such as copper IUCDs, prevent conception primarily by causing a local inflammatory reaction in the uterus. - They do not release hormones and therefore **do not affect coagulation** or increase DVT risk. *Billing's method* - The **Billing's ovulation method** (cervical mucus method) is a natural family planning technique based on observing changes in cervical mucus. - It involves no medications or devices and thus has **no impact on DVT risk**.

Question 41: Which of the following is the most appropriate initial antihypertensive treatment for an elderly patient with isolated systolic hypertension?

A. Amlodipine (Correct Answer)
B. Lisinopril
C. Atenolol
D. Losartan

Explanation: Amlodipine - **Calcium channel blockers (CCBs)**, especially dihydropyridines like amlodipine, are recommended as initial therapy for isolated systolic hypertension in the elderly due to their effectiveness in reducing elevated systolic pressure [2]. - They are well-tolerated and can reduce the risk of cardiovascular events in this population. *Lisinopril* - **ACE inhibitors** like lisinopril are effective antihypertensives but are generally not the first-line choice for isolated systolic hypertension, particularly in elderly patients where a decrease in diastolic pressure might be detrimental [1]. - They are associated with side effects such as **cough** and can cause **acute kidney injury**, which can be a concern in older adults [1]. Atenolol - **Beta-blockers** like atenolol are generally not recommended as first-line therapy for isolated systolic hypertension due to their limited efficacy in lowering systolic blood pressure compared to other drug classes. - They may also worsen certain conditions common in the elderly, such as **peripheral vascular disease** and **bronchospastic lung disease**. *Losartan* - **Angiotensin receptor blockers (ARBs)** like losartan are effective for hypertension but are not typically favored over CCBs or thiazide diuretics as initial monotherapy for isolated systolic hypertension in the elderly [1]. - They share similar side effects and contraindications with ACE inhibitors, including the risk of **renal dysfunction** [1].

Question 42: Megaloblastic anemia should be treated with both folic acid and vitamin B12 because -

A. It is an enzyme
B. It is a cofactor
C. Folic acid alone causes improvement of hematologic symptoms but worsening of neurological symptoms (Correct Answer)
D. None of the above

Explanation: ***Folic acid alone causes improvement of hematologic symptoms but worsening of neurological symptoms*** - Treating **B12 deficiency** with **folic acid alone** can normalize hematologic parameters, which can mask the underlying B12 deficiency. - This can lead to the progression of **irreversible neurological damage** because folic acid does not address the metabolic pathways dependent on B12 for myelin maintenance. *It is an enzyme* - **Folic acid** and **vitamin B12** are not enzymes; they function as **coenzymes** or **cofactors** in metabolic reactions. - Enzymes are proteins that catalyze biochemical reactions, a role not played by these vitamins themselves. *It is a cofactor* - While both **folic acid** and **vitamin B12** are cofactors, this statement alone does not explain why both are needed to treat megaloblastic anemia. - The critical reason for co-administration lies in the potential for **neurological deterioration** if B12 deficiency is missed and only folate is given. *None of the above* - This option is incorrect because there is a valid and specific reason (the neurological consequences mentioned above) for treating megaloblastic anemia with both supplements. - The interaction between **folate** and **B12 metabolism** is crucial in understanding the treatment approach.

Question 43: Absolute contraindication of hormone replacement therapy is:

A. Fibroadenoma
B. Thrombosis (Correct Answer)
C. Fibrocystic disease
D. Hemorrhage

Explanation: ***Thrombosis*** - A history of **thrombosis** (e.g., DVT, pulmonary embolism) is an **absolute contraindication** to hormone replacement therapy (HRT) due to the increased risk of further **thromboembolic events**, as estrogen can promote coagulation [1], [2]. - HRT can increase the risk of **blood clot formation**, making it unsafe for individuals with a prior or current thrombotic condition [1]. *Fibroadenoma* - **Fibroadenomas** are **benign breast lumps** and are generally not considered an absolute contraindication for HRT. - While HRT can potentially cause some **breast density** changes, fibroadenomas do not typically preclude its use, though monitoring may be advised. *Fibrocystic disease* - **Fibrocystic breast disease** is a common **benign breast condition** characterized by lumpy, tender breasts, and it is **not an absolute contraindication** for HRT. - HRT might occasionally exacerbate breast tenderness in some women with fibrocystic changes, but it does not pose a severe health risk. *Hemorrhage* - Acute or uncontrolled **vaginal hemorrhage**, especially of undetermined etiology, is a contraindication to initiating HRT until the cause is identified and managed. - However, once the hemorrhage is controlled and its cause is determined not to be uterine cancer, previous hemorrhage itself is **not an absolute contraindication** to long-term HRT.

Question 44: 1 ml of 7.5% sodium bicarbonate provides:-

A. 0.5 meq bicarbonate
B. 0.9 meq bicarbonate (Correct Answer)
C. 1.5 meq bicarbonate
D. 1.1 meq bicarbonate

Explanation: ***0.9 meq bicarbonate*** - A 7.5% solution means 7.5 grams of sodium bicarbonate in 100 ml of solution. Thus, 1 ml contains **0.075 grams** (75 mg). - The molecular weight of sodium bicarbonate (NaHCO₃) is approximately **84 g/mol**. Since it is a monovalent ion, 1 mmol equals 1 mEq. Therefore, 75 mg is approximately **0.892 mEq**, which rounds to 0.9 mEq. *0.5 meq bicarbonate* - This value is significantly **lower** than the actual amount of bicarbonate contained in 1 ml of a 7.5% solution. - An error in calculation, such as an incorrect molecular weight or percentage conversion, would lead to this underestimation. *1.5 meq bicarbonate* - This value is **higher** than the actual amount of bicarbonate and would be closer to the concentration of a 12.5% solution or a significantly larger volume. - This suggests a **miscalculation** of the concentration or the amount present in 1 ml. *1.1 meq bicarbonate* - While closer than other incorrect options, this value is still an **overestimation**. - A slight error in the molecular weight used for calculation or in the initial mass conversion could lead to this result.

Question 45: What is the typical pH of Hartmann's solution?

A. Has a pH of approximately 5.5
B. Has a pH of approximately 7.4
C. Has a pH of approximately 6.5 (Correct Answer)
D. Has a pH of approximately 8.0
E. Has a pH of approximately 4.5

Explanation: Everything mentioned here pertains to pH values of biological fluids and intravenous solutions. ***Has a pH of approximately 6.5*** - Hartmann's solution, also known as **Lactated Ringer's solution**, typically has a pH of about **6.0 to 7.5**, with 6.5 being a good approximation. - Its slightly acidic nature, compared to physiological pH, is due to the presence of **lactic acid** which is later metabolized to bicarbonate. *Has a pH of approximately 5.5* - A pH of 5.5 is more **acidic** than typical Hartmann's solution and might be found in some other IV fluids like **0.9% normal saline**. - While Hartmann's is slightly acidic, it's generally not as acidic as 5.5. *Has a pH of approximately 7.4* - A pH of 7.4 is the **physiological pH of blood** [1]. - While Hartmann's solution is designed to be **isotonic** and help correct acidosis, its pH is not exactly 7.4 before infusion and metabolism. *Has a pH of approximately 8.0* - A pH of 8.0 is **alkaline** and significantly higher than the typical pH of Hartmann's solution. - Such a high pH would not be safe for routine intravenous administration. *Has a pH of approximately 4.5* - A pH of 4.5 is quite **acidic** and would be much more acidic than Hartmann's solution. - Infusion of a solution with such a low pH could lead to significant **acidosis** and other adverse effects in a patient.

Question 46: A 45-year-old man with type 2 diabetes develops tender hemorrhagic bullae on both legs after starting empagliflozin. Blood glucose is well-controlled. Most appropriate management is:

A. Add topical antibiotics
B. Switch to another SGLT2 inhibitor
C. Continue empagliflozin with wound care
D. Stop empagliflozin (Correct Answer)

Explanation: **Stop empagliflozin** * Empagliflozin, an **SGLT2 inhibitor**, is associated with an increased risk of **bullous pemphigoid**, especially in patients with diabetes. The presentation of **tender hemorrhagic bullae** strongly suggests this adverse drug reaction [1]. * Discontinuation of the offending drug is the **most appropriate initial management** to prevent further lesion development and allow for resolution [1]. *Add topical antibiotics* * Topical antibiotics might be used for **secondary infection** of the bullae, but they do not address the underlying cause of the condition, which is a drug-induced reaction. * Stopping the causative agent is paramount; treating symptoms alone without removing the trigger is insufficient. *Switch to another SGLT2 inhibitor* * Since the bullae are likely an **adverse effect** of the SGLT2 inhibitor class (specifically, association with bullous pemphigoid), switching to another drug within the same class (another SGLT2 inhibitor) would likely result in the recurrence or persistence of the adverse reaction. * Cross-reactivity is common among drugs within the same pharmacological class, especially for immune-mediated skin reactions. *Continue empagliflozin with wound care* * Continuing the drug that is causing a severe skin reaction like bullous pemphigoid is **contraindicated** and would lead to worsening of the condition and potential complications. * While wound care is important for managing the lesions, it does not address the underlying cause, and continuing the medication would prevent healing and increase patient morbidity.

Question 47: A 25-year-old woman with severe nodulocystic acne develops acute-onset fever, arthralgia, and osteolytic lesions while on isotretinoin. Most appropriate next step is:

A. Continue isotretinoin and add NSAIDs
B. Stop isotretinoin, start antibiotics (Correct Answer)
C. Decrease isotretinoin dose
D. Add oral steroids

Explanation: ***Stop isotretinoin, start antibiotics*** - The combination of **fever**, **arthralgia**, and **osteolytic lesions** in the context of isotretinoin use suggests the development of **isotretinoin-induced SAPHO syndrome** (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis). Although rare, it can mimic infection, and given the patient's acute symptoms and systemic involvement, stopping the potential offending agent (isotretinoin) and empirically treating with antibiotics for possible osteomyelitis is the safest initial step [1]. - While SAPHO syndrome is an autoimmune condition, initially ruling out and treating potential infection, especially with osteolytic lesions, is crucial before solely focusing on immunosuppression [2]. *Continue isotretinoin and add NSAIDs* - Continuing isotretinoin is inappropriate as it could be the **trigger** for the patient's systemic symptoms and osteolytic lesions. - While NSAIDs can alleviate arthralgia, they would not address the **underlying systemic inflammation** or potential infection suggested by the osteolytic lesions and fever. *Decrease isotretinoin dose* - Simply decreasing the dose might not be sufficient to halt the progression of an isotretinoin-induced inflammatory or autoimmune response like **SAPHO syndrome**. - The severity of symptoms with **fever** and **osteolytic lesions** warrants complete cessation of the suspected causative agent. *Add oral steroids* - While oral steroids might be considered for the inflammatory component of **SAPHO syndrome**, adding them without stopping the suspected trigger (isotretinoin) is not optimal. - Furthermore, if there's an underlying infection leading to the osteolytic lesions, steroids could worsen the clinical picture by **immunosuppression**.

Question 48: A patient with chronic sinusitis has nasal polyps, aspirin sensitivity, and asthma. Most appropriate treatment is:

A. Early polypectomy
B. Aspirin desensitization (Correct Answer)
C. Antibiotics
D. Topical steroids

Explanation: Aspirin desensitization - The combination of **nasal polyps**, **aspirin sensitivity**, and **asthma** is characteristic of **Aspirin-Exacerbated Respiratory Disease (AERD)**, also known as Samter's triad. - **Aspirin desensitization** is the most effective treatment for AERD as it addresses the underlying inflammatory pathway, leading to improved asthma control, reduced polyp recurrence, and decreased need for oral corticosteroids. *Early polypectomy* - While polypectomy can temporarily relieve symptoms by removing the polyps, it does not address the underlying inflammatory process of **AERD**. - Polyps in AERD patients have a **high recurrence rate** after surgical removal if the underlying aspirin sensitivity is not managed. *Antibiotics* - Antibiotics are used to treat **bacterial infections**, but they do not address the **chronic inflammatory condition** of AERD or the formation of nasal polyps. - Chronic sinusitis in AERD is often an inflammatory, not primarily infectious, process. *Topical steroids* - **Topical nasal steroids** can help manage chronic rhinosinusitis symptoms and may slow polyp growth but are generally insufficient as a sole treatment [1] for patients with established **AERD** and significant symptoms. - They provide **symptomatic relief** but do not modify the disease course in the same comprehensive way as aspirin desensitization.

Question 49: A patient with bronchial asthma develops osteoporosis. Most likely mechanism?

A. Calcium malabsorption
B. Inflammatory mediators
C. Physical inactivity
D. Chronic steroid use (Correct Answer)

Explanation: ***Chronic steroid use*** - **Glucocorticoids**, commonly used in the treatment of bronchial asthma, can directly inhibit **osteoblast activity** and promote **osteoclast activity**, leading to bone loss [1]. - They also reduce intestinal **calcium absorption** and increase **renal calcium excretion**, further disrupting calcium homeostasis and contributing to osteoporosis [1]. *Calcium malabsorption* - While **malabsorption syndromes** can cause osteoporosis, asthma itself does not directly lead to primary calcium malabsorption. - Steroids used in asthma treatment can *contribute* to reduced calcium absorption, but the primary mechanism of steroid-induced osteoporosis involves broader effects on bone metabolism, not solely malabsorption [1]. *Inflammatory mediators* - **Inflammatory mediators** associated with asthma may play a role in bone density loss, but their direct impact is less significant and less common than the effects of chronic steroid use [2]. - While chronic inflammation can indirectly affect bone remodeling, it is not the most likely or direct mechanism for osteoporosis in this clinical scenario compared to steroid exposure [1]. *Physical inactivity* - **Physical inactivity** can contribute to osteoporosis due to reduced mechanical loading on bones, but it is not a direct or primary cause specific to bronchial asthma [3]. - While severe asthma may lead to some activity limitation, the primary mechanism linking asthma treatment to osteoporosis is typically medication-related, rather than lifestyle factors alone.

Question 50: A patient on atorvastatin presents with myalgia; which test is recommended?

A. Liver function test
B. Blood urea nitrogen
C. Serum potassium
D. Creatine kinase (Correct Answer)

Explanation: ***Creatine kinase*** - **Myalgia** in a patient on **atorvastatin** raises concern for **statin-induced myopathy**, which can range from mild muscle aches to severe **rhabdomyolysis** [1]. - **Creatine kinase (CK)** levels are commonly used to assess muscle damage, with significantly elevated levels (e.g., >10 times normal) indicating rhabdomyolysis [1]. *Liver function test* - While atorvastatin can cause **hepatic dysfunction**, **myalgia** is not a primary symptom of liver injury [1]. - **Liver function tests (LFTs)** would be more relevant if the patient presented with jaundice, dark urine, or other signs of liver damage [1]. *Blood urea nitrogen* - **Blood urea nitrogen (BUN)** is a marker of **kidney function**, not directly related to muscle pain or statin-induced myopathy. - While severe **rhabdomyolysis** can lead to **acute kidney injury (AKI)**, BUN would be checked *after* CK levels indicate significant muscle breakdown. *Serum potassium* - **Serum potassium** levels are important for **cardiac and muscle function**, but myalgia itself does not directly indicate a potassium imbalance. - **Hyperkalemia** can occur secondary to severe **rhabdomyolysis** due to the release of intracellular potassium from damaged muscle cells, but CK is the initial diagnostic test for muscle injury.

Question 51: A 50-year-old male with diabetes presents with severe burning pain in his feet. Medications have been ineffective. What is the most appropriate next step in management?

A. Prescribe opioid analgesics
B. Prescribe corticosteroids
C. Trial of pregabalin (Correct Answer)
D. Refer for physical therapy

Explanation: ***Trial of pregabalin*** - **Pregabalin**, a gamma-aminobutyric acid (GABA) analog, is a first-line treatment for **diabetic neuropathic pain** due to its efficacy in modulating neurotransmitter release [2]. - Given that previous medications have been ineffective for **severe burning pain** [1] in diabetic neuropathy, exploring other pharmacological options like pregabalin is the most appropriate next step [2]. *Prescribe opioid analgesics* - **Opioid analgesics** are generally reserved for neuropathic pain that is refractory to other treatments due to concerns about tolerance, dependence, and significant side effects [1]. - They are not considered a first-line or early second-line treatment for **diabetic neuropathy**, especially when other agents like pregabalin have not yet been trialed [2]. *Prescribe corticosteroids* - **Corticosteroids** are potent anti-inflammatory agents but are not indicated for the chronic management of **diabetic neuropathic pain**, which is primarily a nerve damage issue rather than an inflammatory one. - Long-term steroid use carries significant risks and would likely worsen diabetes control, making it an inappropriate choice. *Refer for physical therapy* - **Physical therapy** can be beneficial for managing some aspects of diabetic neuropathy, such as improving balance or muscle strength, but it is unlikely to directly alleviate severe burning neuropathic pain as a primary monotherapy. - While a valuable adjunctive treatment, it is not the most appropriate initial next step for directly addressing severe pain symptoms when pharmacological options are still available [2].

Question 52: A patient presents with a temperature of 40°C and flushed skin. Which of the following interventions is most appropriate to lower the body temperature?

A. Applying a heating blanket
B. Increasing room temperature
C. Providing warm fluids
D. Administering antipyretics (Correct Answer)

Explanation: ***Administering antipyretics*** - **Antipyretics** such as acetaminophen or ibuprofen directly act on the **hypothalamus** to reset the body's thermoregulatory set point, promoting heat loss and reducing fever [1]. - They are the most appropriate first-line intervention for **febrile patients** with a high temperature, as they address the underlying mechanism of fever [3]. *Applying a heating blanket* - This intervention would **increase** the patient's body temperature, which is the opposite of the desired effect for a patient with a fever of 40°C. - **Heating blankets** are used for hypothermia, not hyperthermia. *Increasing room temperature* - Raising the room temperature would make it harder for the patient's body to dissipate heat, potentially leading to a **further increase** in body temperature [1]. - A cooler environment promotes heat loss through **convection** and **radiation** [1], [4]. *Providing warm fluids* - While hydration is important, providing **warm fluids** would add heat to the patient's body, which is counterproductive in this situation [2]. - **Cool or room-temperature fluids** are generally preferred for hydration during fever to avoid contributing to the elevated body temperature [2].

Question 53: Which medication is preferred for treating orthostatic hypotension in an elderly patient with heart failure?

A. Fludrocortisone; increases blood volume
B. Neither; lifestyle modifications are preferred
C. Both are equally appropriate; combine for better effect
D. Midodrine; a direct vasoconstrictor (Correct Answer)

Explanation: ***Midodrine; a direct vasoconstrictor*** - **Midodrine** is an alpha-1 adrenergic agonist that causes **vasoconstriction**, directly increasing peripheral vascular resistance and blood pressure to treat orthostatic hypotension. - It is preferred in patients with **heart failure** because, unlike fludrocortisone, it has minimal effects on plasma volume and does not exacerbate fluid overload, a common concern in heart failure [1]. *Fludrocortisone; increases blood volume* - **Fludrocortisone** is a mineralocorticoid that promotes **sodium and water retention**, thereby increasing intravascular volume. - While effective for orthostatic hypotension, it can worsen **fluid overload** and **heart failure symptoms** due to its volume-expanding properties, making it a less suitable first-line choice in this population [1]. *Neither; lifestyle modifications are preferred* - While **lifestyle modifications** (e.g., increased fluid and salt intake, compression stockings, slow position changes) are crucial for managing orthostatic hypotension, they are often insufficient alone in elderly patients with symptomatic conditions like heart failure. - Pharmacological intervention is frequently required to achieve adequate symptom control and prevent falls [1]. *Both are equally appropriate; combine for better effect* - **Midodrine** and **fludrocortisone** are not equally appropriate for an elderly patient with heart failure, as fludrocortisone poses a higher risk of worsening heart failure due to volume expansion. - Combining medications without careful consideration of potential adverse effects, especially in a vulnerable patient population like those with heart failure, is generally discouraged unless specific indications outweigh the risks.

Question 54: A 72-year-old female with a history of atrial fibrillation on warfarin presents with acute flank pain. A CT scan reveals a large perinephric hematoma. What is the most appropriate management option for this patient?

A. Continue anticoagulation despite the hematoma.
B. Observation with close monitoring without intervention.
C. Surgical evacuation of the hematoma as a first-line treatment.
D. Reversal of anticoagulation to prevent further bleeding in the context of a perinephric hematoma. (Correct Answer)

Explanation: **Reversal of anticoagulation to prevent further bleeding in the context of a perinephric hematoma.** - The presence of a **large perinephric hematoma** in a patient on **warfarin** indicates active bleeding or a significant risk of further bleeding, necessitating immediate reversal of anticoagulation. [1] - Reversal can be achieved using **Vitamin K** and/or **four-factor prothrombin complex concentrate (4F-PCC)**, depending on the urgency and severity of bleeding and the patient's INR. *Continue anticoagulation despite the hematoma.* - Continuing anticoagulation would **exacerbate the bleeding** into the perinephric space, potentially leading to hemodynamic instability, increased pain, and larger hematoma size. - This approach would be **medically irresponsible** given the documented bleeding event, as it would directly oppose efforts to control hemorrhage. *Observation with close monitoring without intervention.* - While monitoring is crucial, **mere observation without intervention** is insufficient when there's an active or high-risk bleed due to anticoagulation, especially with a "large" hematoma. - This approach risks **cardiovascular compromise** from blood loss (e.g., hypovolemic shock) and further kidney damage due to compression from the expanding hematoma. *Surgical evacuation of the hematoma as a first-line treatment.* - **Surgical evacuation** of a perinephric hematoma is typically reserved for cases where bleeding continues despite anticoagulation reversal, there is evidence of **renal ischemia**, or the patient becomes **hemodynamically unstable** despite conservative measures. - It is an **invasive procedure** with associated risks and is not the initial management step when bleeding is likely due to therapeutic anticoagulation.

Question 55: A patient on long-term NSAID therapy develops peptic ulcer disease. What approach should be taken to manage both conditions effectively?

A. Switch to a COX-2 inhibitor and start a proton pump inhibitor (Correct Answer)
B. Continue NSAID and add an H2 receptor antagonist
C. Discontinue NSAID and switch to acetaminophen
D. Add a high-dose antacid regimen

Explanation: ***Switch to a COX-2 inhibitor and start a proton pump inhibitor*** - A **COX-2 inhibitor** provides anti-inflammatory effects with less gastrointestinal toxicity compared to traditional NSAIDs, as it selectively inhibits the COX-2 enzyme which is responsible for inflammation while sparing COX-1, which protects the gastric mucosa [1], [3]. - A **proton pump inhibitor (PPI)** effectively suppresses gastric acid secretion, promoting the healing of existing ulcers and preventing new ones, offering superior protection compared to H2 receptor antagonists for NSAID-induced ulcers. *Continue NSAID and add an H2 receptor antagonist* - Continuing the same **NSAID** would likely exacerbate the peptic ulcer disease due to its non-selective inhibition of COX-1, which is crucial for gastric protection [3]. - **H2 receptor antagonists** are generally less effective than proton pump inhibitors in healing and preventing NSAID-induced ulcers, especially in patients with existing disease [2]. *Discontinue NSAID and switch to acetaminophen* - While discontinuing the NSAID would remove the primary cause of the ulcer, **acetaminophen** may not provide sufficient anti-inflammatory or analgesic effects for the patient's underlying condition requiring long-term NSAID therapy. - This approach might be suitable if the patient's condition for which NSAIDs are prescribed could be managed effectively with a non-NSAID alternative, but it doesn't address the ongoing need for anti-inflammatory treatment. *Add a high-dose antacid regimen* - **Antacids** provide only symptomatic relief by neutralizing stomach acid and do not effectively heal existing ulcers or prevent new ones in the context of ongoing NSAID use [2]. - A high-dose antacid regimen is impractical for long-term management and does not suppress acid production as effectively as PPIs or H2 blockers.

Question 56: In which of the following conditions is hyperbaric oxygen therapy not useful?

A. Compartment Syndrome (Correct Answer)
B. Anemia
C. Gas gangrene
D. Vertigo

Explanation: ***Compartment Syndrome*** - **Hyperbaric oxygen therapy (HBOT)** is not a primary or generally recommended treatment for compartment syndrome. - The main treatment for **compartment syndrome** is urgent surgical fasciotomy to relieve pressure, as HBOT does not address the underlying mechanical compression of vessels and nerves. *Anemia* - While HBOT directly increases dissolved oxygen in plasma, it **does not increase the red blood cell count** or **hemoglobin levels**, which are the fundamental deficiencies in anemia [1]. - Therefore, it is not a primary treatment for anemia, though it can be a supportive measure in severe cases where conventional methods are delayed or insufficient [1]. *Gas gangrene* - **Clostridium perfringens**, the causative agent of gas gangrene, is an **anaerobic bacterium** that thrives in low-oxygen environments. - **Hyperbaric oxygen** creates an oxygen-rich environment that is toxic to these bacteria and enhances the body's immune response, making it an effective adjunctive treatment. *Vertigo* - **Vestibular vertigo** can sometimes be associated with inner ear ischemia or damage from pressure changes, for which HBOT may offer benefit by improving oxygen delivery to the affected tissues [2]. - Its use for vertigo is more investigational, but **improvement in oxygenation and reduction in inflammation** could theoretically alleviate symptoms in certain labyrinthine disorders [2].

Question 57: Which of the following is an absolute CONTRAINDICATION to OCP use:

A. DVT (Correct Answer)
B. Diabetes mellitus
C. History of amenorrhea
D. Chronic renal disease

Explanation: ***DVT*** - A **history of DVT** (deep vein thrombosis) is an absolute contraindication for **combined oral contraceptive pills (OCPs)** due to the increased risk of **thrombosis**. - OCPs, particularly those containing estrogen, elevate the risk of **venous thromboembolism (VTE)** by affecting coagulation factors. *Diabetes mellitus* - **Uncontrolled diabetes** with vascular complications (nephropathy, retinopathy, neuropathy) is generally a contraindication, but **well-controlled diabetes** without these issues is not. - OCPs can slightly affect **glucose metabolism**, but the benefits often outweigh the risks in controlled cases. *History of amenorrhea* - A history of **amenorrhea** (absence of menstruation) is not an absolute contraindication to OCP use. - OCPs can often be used to **regulate menstrual cycles** or in diagnostic workups for amenorrhea. *Chronic renal disease* - **Chronic renal disease** in itself is not an absolute contraindication; the decision depends on the **severity of the disease** and associated complications. - OCP use might require careful monitoring in patients with severe renal impairment, but it is not universally prohibited.

Question 58: Which fluid is ideally given for a patient experiencing dehydration?

A. Plasma
B. Normal Saline (Correct Answer)
C. Blood
D. 5% dextrose

Explanation: ***Normal Saline*** - **Normal saline (0.9% sodium chloride)** is an **isotonic solution** that effectively increases **extracellular fluid volume**, making it ideal for treating **dehydration** and hypovolemia [1]. - It closely mimics the **osmolality of plasma** and stays predominantly in the intravascular space, helping to restore circulating volume [1]. *Plasma* - **Plasma** is primarily used for **coagulation factor deficiencies** or volume expansion in cases of severe **hypoproteinemia**, not routine dehydration. - It contains **proteins and clotting factors** that are not typically needed for simple dehydration and carries risks of **allergic reactions and transfusion-related acute lung injury (TRALI)**. *Blood* - **Blood transfusions** are indicated for patients with **significant anemia** or **acute blood loss**, not for generalized dehydration. - Using blood for dehydration would be inappropriate due to risks such as **transfusion reactions**, **infections**, and **iron overload**. *5% dextrose* - **5% dextrose in water (D5W)** is an **isotonic solution initially**, but once the dextrose is metabolized, it becomes **hypotonic**, causing free water to shift into the cells [1]. - While it provides some free water, it is not ideal for primary rehydration in cases of significant volume depletion due to its lack of electrolytes and potential for causing **hyponatremia** if given in large quantities [1].

Question 59: Use of spironolactone in liver cirrhosis is

A. Decrease edema (Correct Answer)
B. May improve liver function indirectly
C. May decrease afterload
D. May decrease intravascular volume

Explanation: ***Decrease edema*** - Spironolactone is an **aldosterone antagonist** that blocks the effects of aldosterone, which is often elevated in liver cirrhosis. - By antagonizing aldosterone, spironolactone promotes **sodium and water excretion**, directly leading to a reduction in **ascites and peripheral edema** [1]. *May improve liver function indirectly* - While spironolactone manages complications of liver cirrhosis, it does **not directly improve liver function** or reverse liver damage. - Its primary role is in **symptom management**, particularly fluid retention, not in healing the underlying liver disease. *May decrease afterload* - Spironolactone's primary action is on the **kidneys** to promote diuresis; it is **not a vasodilator** and therefore does not directly decrease cardiac afterload. - Any effect on systemic vascular resistance would be minimal and secondary to volume changes rather than a direct vasodilatory property. *May decrease intravascular volume* - Spironolactone **decreases total body sodium and water**, leading to a reduction in extravascular fluid (edema and ascites) [1]. - While it decreases the total amount of fluid in the body, its main effect is on **extravascular volume**, and it's chosen over loop diuretics in cirrhosis to prevent **excessive intravascular depletion** which can worsen renal function.

Question 60: Site for injection of cell culture rabies vaccine-

A. Gluteus
B. Subcutaneous
C. Deltoid (Correct Answer)
D. Anterior abdominal wall

Explanation: Deltoid - The **deltoid muscle** is the recommended site for intramuscular injection of cell culture rabies vaccine due to its size and accessibility [1]. - Intramuscular administration in this area ensures optimal vaccine absorption and immunogenicity [1]. Gluteus - The **gluteus muscle** is not the preferred site for rabies vaccine due to the risk of injecting into fat, which can lead to reduced immune response [1]. - Additionally, there is a higher risk of **sciatic nerve injury** with gluteal injections. Subcutaneous - **Subcutaneous administration** is not the standard route for cell culture rabies vaccines as it can lead to slower absorption and potentially a less robust immune response. - This route is typically reserved for specific vaccine types or in situations where intramuscular injection is contraindicated. Anterior abdominal wall - The **anterior abdominal wall** is an unsuitable site for intramuscular injection of rabies vaccine. - This area is primarily used for **subcutaneous injections** (e.g., insulin) and lacks sufficient muscle mass for effective intramuscular vaccine delivery.

Question 61: Which drug should not be given in a patient with hyperrenninemia?

A. Beta blocker
B. Calcium channel blocker
C. ACE inhibitor
D. None of the options (Correct Answer)

Explanation: None of the options - This is the correct answer because drugs used to treat hypertension often aim to **reduce renin activity** or its effects, making them appropriate for hyperreninemia. - Hyperreninemia indicates an overactive **renin-angiotensin-aldosterone system (RAAS)**, and all the listed drug classes can be used to manage conditions associated with it [2]. *Beta blocker* - **Beta-blockers** reduce renin secretion from the **juxtaglomerular cells** by blocking beta-1 adrenergic receptors [2]. - Therefore, they are often used to *treat* conditions involving high renin levels, making them suitable rather than contraindicated. *Calcium channel blocker* - **Calcium channel blockers** reduce peripheral vascular resistance and can lower blood pressure, but they do not directly inhibit renin secretion [1]. - However, they are not contraindicated in hyperreninemia and may be used as part of a multidrug regimen to control blood pressure. *ACE inhibitor* - **ACE inhibitors** block the conversion of **angiotensin I to angiotensin II**, thus directly interrupting the RAAS pathway [1]. - This action helps to *lower* blood pressure and can be beneficial in hyperreninemia, making it a treatment rather than a contraindicated drug [1].

Question 62: A 42-year-old man was seen in the clinic because of pain and redness in his finger. Last week he had injured the finger while working in his garage. On physical examination, there is erythema, swelling, and tenderness of the second digit in the right hand. Flexion and extension of the finger were normal. A clinical diagnosis of cellulitis is made and he is prescribed cephalexin. A few days later he presents to the emergency room complaining of difficulty breathing. He has angioedema due to a drug reaction to the cephalexin. Which of the following physical findings is characteristic of this syndrome?

A. Invariably severe itching
B. Prolonged nature of the edema
C. Fluid extravasation from subcutaneous and intradermal postcapillary venules
D. Involvement of lips, tongue, eyelids, genitalia, and dorsum of hands or feet (Correct Answer)

Explanation: ***Involvement of lips, tongue, eyelids, genitalia, and dorsum of hands or feet*** - **Angioedema** is characterized by episodic, localized swelling of the deeper dermal and subcutaneous tissues, often affecting the **lips, tongue, eyelids, genitalia, and dorsum of hands or feet** [1]. - This distribution is due to the **loose connective tissue** in these areas, which allows for significant fluid accumulation. *Invariably severe itching* - While angioedema can sometimes be accompanied by itching, **severe itching (pruritus)** is more characteristic of **urticaria** (hives), which involves the superficial dermis [1]. - In many cases of angioedema, particularly **bradykinin-mediated types**, itching is absent or minimal. *Prolonged nature of the edema* - The edema in **angioedema** typically resolves within **24 to 72 hours**, not weeks or months, differentiating it from other chronic inflammatory conditions. - Its self-limiting nature is a key diagnostic feature, although recurrence is common. *Fluid extravasation from subcutaneous and intradermal postcapillary venules* - **Fluid extravasation** from postcapillary venules occurs in both urticaria and angioedema. However, in angioedema, the fluid extravasation occurs at the level of the **deep dermis and subcutaneous tissue**, leading to deeper swelling. - In **urticaria**, the extravasation is more superficial, affecting the **epidermis and superficial dermis**, resulting in itchy wheals.

Question 63: A patient on low-molecular-weight heparin suddenly develops a severe hemorrhage. What test would be most useful to assess the degree of anticoagulation?

A. Stop LMWH immediately (Correct Answer)
B. Transfuse blood products
C. Administer protamine sulfate
D. Consider specific reversal agents

Explanation: ***Stop LMWH immediately*** - The immediate priority in severe hemorrhage due to **low-molecular-weight heparin (LMWH)** is to cease further administration of the anticoagulant. [1] - This prevents worsening of the bleeding by halting the delivery of more drug that could contribute to the **anticoagulant effect**, thus allowing natural clotting mechanisms to begin recovery. [1] *Administer protamine sulfate* - While **protamine sulfate** is a reversal agent for LMWH, its efficacy is only partial (about 60-75% neutralization of anti-Xa activity) compared to its effect on unfractionated heparin. - Therefore, it is a secondary step after stopping the drug itself and may not fully reverse the severe hemorrhage. *Transfuse blood products* - **Transfusion of blood products** (e.g., packed red blood cells, fresh frozen plasma, platelets) addresses the consequences of severe hemorrhage (e.g., anemia, coagulopathy) but does not directly neutralize the anticoagulant effect of LMWH. - This is a supportive measure, crucial for managing blood loss and maintaining hemodynamic stability, but not the primary action to stop the drug's effect. *Consider specific reversal agents* - **Specific reversal agents** for LMWH itself are limited; protamine sulfate is the primary option, albeit with partial efficacy. - Newer agents for direct oral anticoagulants might be considered in other contexts, but for LMWH, stopping the drug is the most immediate and universally applicable action.

Question 64: What is the MOST COMMON side effect of vagal nerve stimulation?

A. nausea
B. coughing
C. voice changes (Correct Answer)
D. throat discomfort

Explanation: ***voice changes*** - **Voice changes**, such as **hoarseness** or dysphonia, are the most frequently reported side effect due to the proximity of the stimulator to the **recurrent laryngeal nerve** [1]. - These changes often occur during stimulation and can be managed by adjusting the device settings. *coughing* - While **coughing** can occur, it is a less common side effect compared to voice changes. - It results from irritation of the **laryngeal or pharyngeal branches** of the vagus nerve. *nausea* - **Nausea** is a less common side effect and typically occurs due to activation of the **gastrointestinal afferent fibers** of the vagus nerve [2]. - It usually resolves with adjustment of stimulation parameters or over time. *throat discomfort* - **Throat discomfort** or pain can occur, but it is less frequent than voice changes and may be associated with the surgical implantation site or local irritation from the lead. - It is distinct from the functional changes in voice caused by direct nerve stimulation.

Question 65: A 45-year-old woman who underwent a modified radical mastectomy 4 years ago and was treated for multiple bone metastases with cyclophosphamide, doxorubicin, and fluorouracil for 6 months is complaining of exertional dyspnea, swelling of the legs, and periorbital edema in the morning. On examination, she has bilateral rales in the lungs, and her cardiovascular examination reveals a palpable S1, S2, S3, and S4 gallop. Her blood pressure is 149/117 mmHg, pulse rate is 80/min, and respiratory rate is 18/min. What is the most likely cause of her cardiac condition?

A. Pneumonia
B. Drug induced cardiac toxicity (Correct Answer)
C. Cardiac involvement from metastasis or heart failure
D. Systolic dysfunction due to heart failure secondary to drug toxicity

Explanation: ***Drug induced cardiac toxicity*** - The patient's history of treatment with **doxorubicin**, an **anthracycline**, is a significant risk factor for **dose-dependent cardiotoxicity**, which can manifest years after cessation of therapy. [1] - Symptoms like **exertional dyspnea**, **leg swelling**, **periorbital edema**, and findings such as **rales**, **hypertension**, and gallop rhythms (**S3 and S4**) are consistent with **heart failure** secondary to cardiotoxicity. [1] *Cardiac involvement from metastasis or heart failure* - While metastatic disease can involve the heart, it's less common for it to present as isolated **cardiac dysfunction** without other prominent metastatic symptoms, especially 4 years post-treatment. - Heart failure is present, but **drug toxicity** is the more specific and likely underlying cause given her treatment history, rather than a general term like "cardiac involvement from metastasis." *Pneumonia* - Although **rales** are present, there is no mention of fever, cough with sputum, or leukocytosis, which are typical signs of **pneumonia**. - The chronicity of symptoms (dyspnea, edema) and the presence of **S3 and S4 gallops** are more indicative of a **chronic cardiac condition** than an acute infection. [1] *Systolic dysfunction due to heart failure secondary to drug toxicity* - This option is partially correct but less comprehensive than "Drug induced cardiac toxicity." While **systolic dysfunction** and **heart failure** are consequences, "drug induced cardiac toxicity" is the direct and primary cause. [1] - The question asks for the "most likely cause of her cardiac condition," and the toxicity itself is the etiology leading to the dysfunction and failure.

Question 66: What is the etiology of the rash in a 20-year-old college student who presented with fever, sore throat, and malaise, and was previously diagnosed with streptococcal pharyngitis and treated with intramuscular ampicillin, despite having no history of travel?

A. Exanthematous drug eruption (Correct Answer)
B. Parvovirus B19 infection
C. Chikungunya virus infection
D. Measles infection

Explanation: ***Exanthematous drug eruption*** - This patient's history of **ampicillin administration** for streptococcal pharyngitis, followed by the development of a rash, points strongly to an **exanthematous drug eruption** [1]. - **Ampicillin** and amoxicillin are known to cause a maculopapular rash in patients with **Epstein-Barr virus (EBV) infection**, which can present with similar symptoms to streptococcal pharyngitis (fever, sore throat, malaise), making this the most likely scenario [1]. *Parvovirus B19 infection* - **Parvovirus B19** causes **Fifth disease**, characterized by a "slapped cheek" rash on the face and a lacy rash on the trunk and extremities, which is not described. - While it can cause fever and malaise, the preceding **streptococcal pharyngitis** and **ampicillin use** make a drug reaction more probable. *Chikungunya virus infection* - **Chikungunya virus** typically presents with severe **arthralgia**, fever, and rash, often in patients with recent travel to endemic areas. - The patient has no history of travel, and **arthralgia** is not mentioned as a primary symptom. *Measles infection* - **Measles** presents with a characteristic **maculopapular rash** that starts on the face and spreads downwards, often preceded by **Koplik spots**. - While measles causes fever and malaise, the diagnosis of **streptococcal pharyngitis** and subsequent **ampicillin use** strongly suggest a drug-induced rash rather than measles.

Question 67: All are used for management of hyperkalemia except?

A. Insulin plus dextrose
B. Beta 2 agonist
C. Calcium gluconate
D. ACE inhibitors (Correct Answer)

Explanation: ***ACE inhibitors*** - **ACE inhibitors** (Angiotensin-Converting Enzyme inhibitors) are a common cause of **hyperkalemia** because they block the production of aldosterone, which normally promotes potassium excretion [1]. - Therefore, ACE inhibitors would worsen hyperkalemia rather than treat it. *Insulin plus dextrose* - **Insulin** drives potassium into cells, thereby lowering serum potassium levels; **dextrose** is given concurrently to prevent hypoglycemia [1]. - This is a rapid and effective treatment for acute hyperkalemia, especially in emergent situations [1]. *Beta 2 agonist* - **Beta-2 adrenergic agonists** (e.g., albuterol) stimulate the sodium-potassium pump, promoting the intracellular shift of potassium. - This effect helps to decrease extracellular potassium levels, making it a viable treatment option for hyperkalemia. *Calcium gluconate* - **Calcium gluconate** does not lower serum potassium levels but stabilizes the cardiac cell membrane potential, reducing the risk of arrhythmias caused by hyperkalemia [1]. - It is often the first-line treatment in hyperkalemic emergencies with ECG changes [1].

Practice by Chapter

Pharmacokinetics and Pharmacodynamics

Practice Questions

Drug Metabolism and Excretion

Practice Questions

Adverse Drug Reactions and Interactions

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Pharmacogenomics and Precision Medicine

Practice Questions

Drug Development and Clinical Trials

Practice Questions

Rational Prescribing and Deprescribing

Practice Questions

Medication Adherence Strategies

Practice Questions

Special Populations (Pediatric, Geriatric, Pregnancy)

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free